<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Biol</journal-id><journal-id journal-id-type="publisher-id">pbio</journal-id><journal-id journal-id-type="publisher-id">plbi</journal-id><journal-id journal-id-type="pmc">plosbiol</journal-id><journal-title>PLoS Biology</journal-title><issn pub-type="ppub">1544-9173</issn><issn pub-type="epub">1545-7885</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1371/journal.pbio.1000025</article-id><article-id pub-id-type="publisher-id">08-PLBI-RA-0162R4</article-id><article-id pub-id-type="sici">plbi-07-01-20</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Cardiovascular Disorders</subject><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Neuropilin-1/GIPC1 Signaling Regulates &#x003b1;5&#x003b2;1 Integrin Traffic and Function in Endothelial Cells</article-title><alt-title alt-title-type="running-head">Neuropilin-1 Regulates &#x003b1;5&#x003b2;1 Integrin Function</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Valdembri</surname><given-names>Donatella</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Caswell</surname><given-names>Patrick T</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Anderson</surname><given-names>Kurt I</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Schwarz</surname><given-names>Juliane P</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>K&#x000f6;nig</surname><given-names>Ireen</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Astanina</surname><given-names>Elena</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Caccavari</surname><given-names>Francesca</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Norman</surname><given-names>Jim C</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Humphries</surname><given-names>Martin J</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Bussolino</surname><given-names>Federico</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Serini</surname><given-names>Guido</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">&#x0002a;</xref></contrib></contrib-group><aff id="aff1"><label>1</label> Department of Oncological Sciences and Division of Molecular Angiogenesis, Institute for Cancer Research and Treatment, University of Torino School of Medicine, Candiolo, Italy </aff><aff id="aff2"><label>2</label> Beatson Institute for Cancer Research, Bearsden, Glasgow, United Kingdom </aff><aff id="aff4"><label>4</label> Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom </aff><aff id="aff3"><label>3</label> Center for Complex Systems in Molecular Biology and Medicine, University of Torino, Torino, Italy </aff><contrib-group><contrib contrib-type="editor"><name><surname>Stemple</surname><given-names>Derek L</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Wellcome Trust Sanger Institute, United Kingdom</aff><author-notes><corresp id="cor1">&#x0002a; To whom correspondence should be addressed. E-mail: <email>guido.serini&#x00040;ircc.it</email></corresp></author-notes><pub-date pub-type="ppub"><month>1</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>27</day><month>1</month><year>2009</year></pub-date><volume>7</volume><issue>1</issue><elocation-id>e1000025</elocation-id><history><date date-type="received"><day>15</day><month>1</month><year>2008</year></date><date date-type="accepted"><day>11</day><month>12</month><year>2008</year></date></history><copyright-statement><bold>Copyright:</bold> &#x000a9; 2009 Valdembri et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2009</copyright-year><abstract><p>Neuropilin 1 (Nrp1) is a coreceptor for vascular endothelial growth factor A165 (VEGF-A165, VEGF-A164 in mice) and semaphorin 3A (SEMA3A). Nevertheless, <italic>Nrp1</italic> null embryos display vascular defects that differ from those of mice lacking either VEGF-A164 or Sema3A proteins. Furthermore, it has been recently reported that Nrp1 is required for endothelial cell (EC) response to both VEGF-A165 and VEGF-A121 isoforms, the latter being incapable of binding Nrp1 on the EC surface. Taken together, these data suggest that the vascular phenotype caused by the loss of <italic>Nrp1</italic> could be due to a VEGF-A164/SEMA3A-independent function of Nrp1 in ECs, such as adhesion to the extracellular matrix. By using RNA interference and rescue with wild-type and mutant constructs, we show here that Nrp1 through its cytoplasmic SEA motif and independently of VEGF-A165 and SEMA3A specifically promotes &#x003b1;5&#x003b2;1-integrin-mediated EC adhesion to fibronectin that is crucial for vascular development. We provide evidence that Nrp1, while not directly mediating cell spreading on fibronectin, interacts with &#x003b1;5&#x003b2;1 at adhesion sites. Binding of the homomultimeric endocytic adaptor GAIP interacting protein C terminus, member 1 (GIPC1), to the SEA motif of Nrp1 selectively stimulates the internalization of active &#x003b1;5&#x003b2;1 in Rab5-positive early endosomes. Accordingly, GIPC1, which also interacts with &#x003b1;5&#x003b2;1, and the associated motor myosin VI (Myo6) support active &#x003b1;5&#x003b2;1 endocytosis and EC adhesion to fibronectin. In conclusion, we propose that Nrp1, in addition to and independently of its role as coreceptor for VEGF-A165 and SEMA3A, stimulates through its cytoplasmic domain the spreading of ECs on fibronectin by increasing the Rab5/GIPC1/Myo6-dependent internalization of active &#x003b1;5&#x003b2;1. Nrp1 modulation of &#x003b1;5&#x003b2;1 integrin function can play a causal role in the generation of angiogenesis defects observed in <italic>Nrp1</italic> null mice.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><sec id="st1"><title/><p>The vascular system is a hierarchical network of blood vessels lined by endothelial cells that, by means of the transmembrane integrin proteins, bind to the surrounding proteinaceous extracellular matrix (ECM). Integrins are required for proper cardiovascular development and exist in bent (inactive) and extended (active) shapes that are correspondingly unable and able to attach to the ECM. Extracellular guidance cues, such as vascular endothelial growth factor and semaphorins, bind the transmembrane protein neuropilin-1 (Nrp1) and then activate biochemical signals that, respectively, activate or inactivate endothelial integrins. Here, we show that Nrp1, via its short cytoplasmic domain and independently of vascular endothelial growth factor and semaphorins, specifically promotes endothelial cell attachment to the ECM protein fibronectin, which is known to be crucial for vascular development. Notably, Nrp1 favors cell adhesion by associating with fibronectin-binding integrins and promoting the fast vesicular traffic of their extended form back and forth from the endothelial cell-to-ECM contacts. Binding of the Nrp1 cytoplasmic domain with the adaptor protein GIPC1, which in turn associates with proteins required for integrin internalization and vesicle motility, is required as well. It is likely that such an integrin treadmill could act as a major regulator of cell adhesion in general.</p></sec></abstract><abstract abstract-type="toc"><p>The transmembrane protein neuropilin-1 promotes endothelial cell attachment to the extracellular matrix by enhancing active integrin treadmilling at cell-adhesion sites.</p></abstract><counts><page-count count="1"/></counts><custom-meta-wrap><custom-meta><meta-name>citation</meta-name><meta-value>Valdembri D, Caswell PT, Anderson KI, Schwarz JP, K&#x000f6;nig I, et al. (2009) Neuropilin-1/GIPC1 signaling regulates &#x003b1;5&#x003b2;1 integrin traffic and function in endothelial cells. PLoS Biol 7(1): e1000025. doi:<ext-link ext-link-type="doi" xlink:href="10.1371/journal.pbio.1000025">10.1371/journal.pbio.1000025</ext-link></meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec id="s1"><title>Introduction</title><p>In vertebrates, the development of a hierarchically organized and functional vascular tree relies on the dynamic interaction of endothelial cells (ECs) with the surrounding extracellular matrix (ECM), which is mediated by heterodimeric &#x003b1;&#x003b2; integrin adhesive receptors &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b001">1</xref>&#x0005d;. During evolution, vertebrates have acquired an additional set of adhesion-related genes that regulate blood vessel assembly and function &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b002">2</xref>&#x0005d;. Among these genes, the ECM protein fibronectin (FN) and &#x003b1;5&#x003b2;1 integrin, the predominant FN receptor, have proven to be essential for embryonic vascular development and tumor angiogenesis &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b003">3</xref>&#x0005d;. Indeed, in vertebrate embryos FN is the earliest and most abundantly expressed subendothelial matrix molecule &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b003">3</xref>,<xref ref-type="bibr" rid="pbio-1000025-b004">4</xref>&#x0005d;. Endothelial &#x003b1;5&#x003b2;1 mediates cell adhesion to FN and the assembly of soluble FN dimers (sFN) into a fibrillar network &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b003">3</xref>&#x0005d;, which has also been implicated in branching morphogenesis &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b005">5</xref>&#x0005d;.</p><p>The biological activities of integrins depend on the dynamic regulation of their adhesive function in space and time. In cells, integrins exist in different conformations that determine their affinities for ECM proteins &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b006">6</xref>&#x0005d; and are continuously endocytosed, trafficked through endosomal compartments, and recycled back to the plasma membrane &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b007">7</xref>,<xref ref-type="bibr" rid="pbio-1000025-b008">8</xref>&#x0005d;. Therefore, during vascular morphogenesis, real-time modulation of EC&#x02013;ECM adhesion can result from two interconnected phenomena: the regulation of integrin conformation and traffic in response to extracellular stimuli &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b008">8</xref>,<xref ref-type="bibr" rid="pbio-1000025-b009">9</xref>&#x0005d;. Indeed, there is mounting evidence that pro- and antiangiogenic cues regulate blood vessel formation by modulating integrin function &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b001">1</xref>&#x0005d;. In this respect, the transmembrane glycoprotein neuropilin 1 (Nrp1), which is expressed in both neurons and ECs &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b010">10</xref>&#x0005d;, is remarkable because it was originally identified as a surface protein mediating cell adhesion &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b011">11</xref>&#x0005d; and then found to also act as a coreceptor for both pro- and antiangiogenic factors, such as vascular endothelial growth factor A 165 (VEGF-A165, VEGF-A164 in mice) &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b012">12</xref>,<xref ref-type="bibr" rid="pbio-1000025-b013">13</xref>&#x0005d; and semaphorin 3A (SEMA3A) &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b014">14</xref>&#x02013;<xref ref-type="bibr" rid="pbio-1000025-b020">20</xref>&#x0005d;, respectively.</p><p>The extracellular region of Nrp1 contains two repeated complement-binding domains (CUB domains; a1-a2 domains), two coagulation-factor-like domains (b1-b2 domains), and a juxtamembrane meprin/A5/&#x003bc;-phosphatase (MAM; c) homology domain. The Nrp1 intracellular region is only 50 amino acids in length, and its function is poorly characterized &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b021">21</xref>&#x0005d;. Through its b1-b2 domains, Nrp1 binds and potentiates the proangiogenic activity of VEGF-A165, which contains the heparin-binding peptide encoded by exon 7 &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b013">13</xref>&#x0005d;. In addition, Nrp1 acts as the ligand-binding subunit of the receptor complex for the antiangiogenic SEMA3A &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b014">14</xref>&#x02013;<xref ref-type="bibr" rid="pbio-1000025-b020">20</xref>&#x0005d;, whose sema and immunoglobulin-basic domains, respectively, bind the a1-a2 and b1-b2 domains of Nrp1 &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b021">21</xref>&#x0005d;. The MAM/c domain instead mediates the SEMA3A-elicited Nrp1 oligomerization that is required for SEMA3A biological activity &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b021">21</xref>&#x0005d;. Interestingly, the short cytoplasmic domain of Nrp1 is not required for SEMA3A signaling in neurons &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b022">22</xref>&#x0005d;. In addition, the extracellular b1-b2 domains of Nrp1 mediate heterophilic cell adhesion independently of VEGF-A165 and SEMA3A &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b011">11</xref>&#x0005d;.</p><p><italic>Nrp1</italic> null mice display an embryonic lethal phenotype, characterized by dramatic vascular defects ascribed to impaired angiogenic sprouting &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b023">23</xref>&#x0005d;, branching &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b024">24</xref>&#x0005d;, or arterialization &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b025">25</xref>&#x0005d; that is significantly more severe than and/or qualitatively different from that of mice lacking either VEGF-A164 (<italic>VEGF<sup>120/120</sup></italic> mice) &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b026">26</xref>&#x0005d; or Sema3A &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b016">16</xref>&#x0005d;. Indeed, although <italic>Nrp1</italic><sup>&#x02013;/&#x02013;</sup> embryos die in utero by 13.5 days postcopulation &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b023">23</xref>&#x0005d;, <italic>VEGF<sup>120/120</sup></italic> pups are recovered at birth at a normal Mendelian frequency &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b027">27</xref>&#x0005d;. Moreover, a major feature of <italic>Nrp1</italic> null mutants, i.e., the severe impairment of neural tube vascularization &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b023">23</xref>&#x0005d;, is not phenocopied by <italic>VEGF<sup>120/120</sup></italic> mouse embryos &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b026">26</xref>&#x0005d;. In addition, differently from <italic>Nrp1</italic> null mice &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b023">23</xref>,<xref ref-type="bibr" rid="pbio-1000025-b024">24</xref>&#x0005d;, the vascular phenotype of <italic>Sema3a</italic> null mice is significantly influenced by the genetic background &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b016">16</xref>,<xref ref-type="bibr" rid="pbio-1000025-b028">28</xref>&#x02013;<xref ref-type="bibr" rid="pbio-1000025-b030">30</xref>&#x0005d;. These findings suggest that the vascular defects caused by the loss of <italic>Nrp1</italic> could be due to a VEGF-A164/SEMA3A-independent function of Nrp1 in vascular cells, such as adhesion to the ECM &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b031">31</xref>,<xref ref-type="bibr" rid="pbio-1000025-b032">32</xref>&#x0005d;. However, how Nrp1 regulates integrin-dependent EC linkages to the surrounding matrix is still obscure. Here, we shed light on the molecular mechanisms by which Nrp1, via its short cytoplasmic domain and independently of VEGF-A165 and SEMA3A, specifically controls a biological function that is crucial for vascular development &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b003">3</xref>&#x0005d;, namely, &#x003b1;5&#x003b2;1-mediated EC adhesion to FN<italic>.</italic></p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Nrp1 Specifically Promotes EC Adhesion to FN and FN Fibrillogenesis</title><p>To understand the mechanisms by which Nrp1 modulates EC adhesion to different ECM proteins, we silenced the expression of Nrp1 in human umbilical artery ECs by RNA interference (RNAi). Parenthetically, Nrp1 has been found to be expressed at higher levels in arteries than in veins &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b033">33</xref>&#x0005d;. Endothelial cells were transfected twice with either a pool of three different small interfering RNAs (siRNAs) targeting human Nrp1 (si<italic>h</italic>Nrp1) or control nontargeting siRNA (siCtl). Twenty-four hours after the second transfection, Western blot analysis revealed that, in comparison with control cells, Nrp1 protein, but neither &#x003b2;-tubulin nor the Nrp1 interactor GAIP interacting protein C terminus, member 1 (GIPC1), was successfully silenced in si<italic>h</italic>Nrp1 ECs (<xref ref-type="fig" rid="pbio-1000025-g001">Figure 1</xref>A).</p><fig id="pbio-1000025-g001" position="float"><label>Figure 1</label><caption><title>Nrp1 Is Required for EC Adhesion to FN and FN Fibrillogenesis</title><p>(A) Western blot analysis of protein expression in human ECs silenced for Nrp1 (si<italic>h</italic>Nrp1) or transfected with control siRNA (siCtl).</p><p>(B&#x02013;E) Comparison between siCtl (black lines) and si<italic>h</italic>Nrp1 (red lines) transfected ECs adhering to different ECM proteins, i.e., FN (B), VT (C), COLL-I (D), and LN (E).</p><p>(F&#x02013;G) Confocal scanning microscopy analysis of endogenous FN fibrils in siCtl (F) or si<italic>h</italic>Nrp1 (G) transfected ECs. DAPI was used to stain nuclei. White bar in (F) corresponds to 50 &#x003bc;m.</p></caption><graphic xlink:href="pbio.1000025.g001"/></fig><p>Next, we investigated the effect of Nrp1 silencing on EC adhesion to different ECM proteins. Fibronectin, vitronectin (VN), and type I collagen (COLL-I) are typical constituents of the provisional angiogenic ECM &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b001">1</xref>,<xref ref-type="bibr" rid="pbio-1000025-b003">3</xref>&#x0005d;, whereas laminin (LN) isoforms are major components of the vascular basement membrane surrounding both immature and mature blood vessels &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b034">34</xref>&#x0005d;. Short-term (15 min) adhesion assays showed that loss of Nrp1 greatly reduced EC adhesion to FN but not to VN, COLL-I, or LN (<xref ref-type="fig" rid="pbio-1000025-g001">Figure 1</xref>B&#x02013;E), suggesting that positive modulation of cell adhesion by Nrp1 is not a general phenomenon &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b031">31</xref>&#x0005d; but rather a function restricted to specific ECM proteins, such as FN.</p><p>Because FN polymerization by ECs has been suggested to participate in vascular morphogenesis &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b003">3</xref>&#x0005d;, we next examined the role of Nrp1 in the fibrillogenesis of endogenous FN. During FN matrix assembly, current models envisage the binding of sFN to surface integrins, thus causing the conversion of FN to a conformational form that favors fibril formation through interactions with other integrin-bound FN dimers &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b003">3</xref>&#x0005d;. Endothelial cells were cultured in a medium containing FN-depleted fetal calf serum, and accumulation of endogenous FN into fibrils was then detected by confocal immunofluorescence analysis. In comparison with control cells, si<italic>h</italic>Nrp1 ECs were impaired in their ability to incorporate endogenous sFN into a dense fibrillar network 3 h after plating (<xref ref-type="fig" rid="pbio-1000025-g001">Figure 1</xref>F and <xref ref-type="fig" rid="pbio-1000025-g001">1</xref>G). Time-course real-time reverse transcription PCR (RT-PCR) and Western blot analyses revealed that the endogenous FN fibrillogenesis defect observed in si<italic>h</italic>Nrp1 ECs was not due to a reduction in FN mRNA (<xref ref-type="supplementary-material" rid="pbio-1000025-sg001">Figure S1</xref>A) or protein (<xref ref-type="supplementary-material" rid="pbio-1000025-sg001">Figure S1</xref>D). Hence, Nrp1 specifically promotes EC adhesion to FN and FN matrix formation.</p></sec><sec id="s2b"><title>The Cytoplasmic Domain of Nrp1 Controls EC Adhesion to FN Independently of VEGF-A165 and SEMA3A</title><p>To start dissecting the mechanisms by which Nrp1 controls the interaction of human ECs with FN, we sought to compare the abilities of full-length and deletion constructs of mouse Nrp1 (<italic>m</italic>Nrp1) to rescue the adhesion and fibrillogenesis defects of si<italic>h</italic>Nrp1 ECs (<xref ref-type="fig" rid="pbio-1000025-g002">Figure 2</xref>). In particular, we investigated the role played by the extracellular and cytoplasmic moieties of Nrp1. Indeed, the Nrp1 cytodomain, although dispensable for SEMA3A collapsing activity in neurons &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b022">22</xref>&#x0005d;, could signal in cultured ECs &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b035">35</xref>&#x0005d;. Moreover, the C-terminal SEA sequence of Nrp1 interacts with the PDZ domain of the endocytic adaptor protein GIPC1 &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b036">36</xref>&#x0005d;, whose knockdown during development results in altered arterial branching &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b037">37</xref>&#x0005d;. Therefore, we transduced si<italic>h</italic>Nrp1 ECs with retroviral vectors carrying the hemagglutinin (HA)-tagged full-length (<italic>m</italic>Nrp1) and deletion mutants of murine Nrp1 (<xref ref-type="fig" rid="pbio-1000025-g002">Figure 2</xref>A), lacking either the C-terminal SEA amino acids (<italic>m</italic>Nrp1dSEA) or the whole cytoplasmic domain (<italic>m</italic>Nrp1dCy). The si<italic>h</italic>Nrp1 pool did not target any of the <italic>m</italic>Nrp1 constructs, and immunoprecipitation experiments on membrane-biotinylated cell monolayers revealed that all three transmembrane proteins were efficiently exposed on the cell surface (<xref ref-type="fig" rid="pbio-1000025-g002">Figure 2</xref>B).</p><fig id="pbio-1000025-g002" position="float"><label>Figure 2</label><caption><title>Nrp1 Regulates EC Adhesion to FN and FN Fibrillogenesis via Its Cytoplasmic Domain</title><p>(A) Schematic representation of <italic>m</italic>Nrp1 full-length and deletion mutants.</p><p>(B) Western blot analysis of endogenous <italic>h</italic>Nrp1, exogenously transduced <italic>m</italic>Nrp1 constructs, and endogenous &#x003b2;-tubulin expression in ECs transfected with siCtl or si<italic>h</italic>Nrp1 and afterward transduced with PINCO retrovirus carrying <italic>m</italic>Nrp1 constructs. Western blot analysis of biotinylated <italic>m</italic>Nrp1 constructs reveals their correct expression on the surface of ECs.</p><p>(C) Comparison of wild-type full-length <italic>m</italic>Nrp1 (<italic>m</italic>Nrp1) and <italic>m</italic>Nrp1dSEA and <italic>m</italic>Nrp1dCy efficiency in rescuing the defective adhesion of si<italic>h</italic>Nrp1 ECs to FN.</p><p>(D&#x02013;F) Impairment of FN fibrillogenesis in si<italic>h</italic>Nrp1 ECs is rescued by <italic>m</italic>Nrp1 (D) but not by <italic>m</italic>Nrp1dSEA (E) and <italic>m</italic>Nrp1dCy constructs (F). DAPI was used to stain nuclei. White bar in (D) corresponds to 50 &#x003bc;m.</p><p>(G) <italic>m</italic>Nrp1 overexpression stimulates NIH 3T3 fibroblast adhesion to FN, whereas neither <italic>m</italic>Nrp1dSEA nor <italic>m</italic>Nrp1dCy is active in this respect.</p><p>(H,I) Silencing <italic>h</italic>Nrp1 completely blocks VEGF-A165-dependent stimulation (H) and SEMA3A-dependent inhibition (I) of human EC adhesion to FN.</p><p>(J) Silencing <italic>h</italic>Nrp1 in ECs does not impair the <italic>h</italic>Nrp2-dependent inhibition of cell adhesion to FN by SEMA3F.</p></caption><graphic xlink:href="pbio.1000025.g002"/></fig><p>In comparison to wild-type <italic>m</italic>Nrp1, both <italic>m</italic>Nrp1dSEA and <italic>m</italic>Nrp1dCy constructs were severely impaired in their abilities to rescue si<italic>h</italic>Nrp1 EC defects in adhesion to FN (<xref ref-type="fig" rid="pbio-1000025-g002">Figure 2</xref>C) and endogenous FN fibrillogenesis (<xref ref-type="fig" rid="pbio-1000025-g002">Figure 2</xref>D&#x02013;F). Accordingly, only <italic>m</italic>Nrp1 overexpression stimulated the adhesion of NIH 3T3 fibroblasts to FN, whereas neither <italic>m</italic>Nrp1dSEA nor <italic>m</italic>Nrp1dCy were active in this respect (<xref ref-type="fig" rid="pbio-1000025-g002">Figure 2</xref>G). Moreover, <italic>m</italic>Nrp1 overexpression did not promote NIH 3T3 adhesion to VN (<xref ref-type="supplementary-material" rid="pbio-1000025-sg002">Figure S2</xref>), further supporting the concept that Nrp1 behaves as a substrate-specific enhancer of cell adhesion. Hence, it appears that the cytoplasmic domain of Nrp1, in particular its SEA motif, which interacts with the endocytic adaptor GIPC1 &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b036">36</xref>&#x0005d;, is required for Nrp1 stimulation of EC spreading on FN and polymerization of endogenous FN.</p><p>Opposing autocrine loops of VEGF-A &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b038">38</xref>&#x02013;<xref ref-type="bibr" rid="pbio-1000025-b041">41</xref>&#x0005d; and SEMA3A &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b016">16</xref>,<xref ref-type="bibr" rid="pbio-1000025-b019">19</xref>,<xref ref-type="bibr" rid="pbio-1000025-b042">42</xref>,<xref ref-type="bibr" rid="pbio-1000025-b043">43</xref>&#x0005d; have been found in ECs both in vitro and in vivo. Therefore, we investigated whether the SEA motif and the full cytoplasmic domain of Nrp1 could be required for the modulation of EC adhesion to FN by VEGF-A165 and SEMA3A. Consistent with previous observations &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b016">16</xref>,<xref ref-type="bibr" rid="pbio-1000025-b018">18</xref>,<xref ref-type="bibr" rid="pbio-1000025-b020">20</xref>,<xref ref-type="bibr" rid="pbio-1000025-b044">44</xref>&#x0005d;, silencing Nrp1 completely blocked VEGF-A165-dependent stimulation (<xref ref-type="fig" rid="pbio-1000025-g002">Figure 2</xref>H) and SEMA3A-dependent inhibition (<xref ref-type="fig" rid="pbio-1000025-g002">Figure 2</xref>I) of human EC adhesion to FN. As expected, inhibition of cell adhesion to FN by SEMA3F, which signals through Nrp2 &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b020">20</xref>,<xref ref-type="bibr" rid="pbio-1000025-b021">21</xref>&#x0005d;, was not affected by Nrp1 knockdown (<xref ref-type="fig" rid="pbio-1000025-g002">Figure 2</xref>J). Moreover, similarly to what was observed for SEMA3A in neurons &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b022">22</xref>&#x0005d;, we found that the cytoplasmic domain of Nrp1 is entirely dispensable for both VEGF-A165 (<xref ref-type="fig" rid="pbio-1000025-g002">Figure 2</xref>H) and SEMA3A (<xref ref-type="fig" rid="pbio-1000025-g002">Figure 2</xref>I) activity on EC adhesion to FN, because all three <italic>m</italic>Nrp1 constructs rescued si<italic>h</italic>Nrp1 EC response to these factors with a similar efficiency. Thus, the Nrp1 SEA motif and cytodomain are required for Nrp1 modulation of EC adhesion to FN and sFN incorporation into fibrils but not for Nrp1 activity as a VEGF-A165 and SEMA3A coreceptor.</p></sec><sec id="s2c"><title>Nrp1 Regulation of Cell Adhesion Depends on &#x003b1;5&#x003b2;1 Integrin</title><p>&#x003b1;5&#x003b2;1 Integrin is the main FN receptor in ECs &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b001">1</xref>,<xref ref-type="bibr" rid="pbio-1000025-b003">3</xref>&#x0005d;, and by transmitting the actin-dependent tension to sFN, it triggers FN fibrillogenesis &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b045">45</xref>&#x0005d;. To elucidate whether Nrp1 stimulation of cell adhesion to FN was directly mediated by Nrp1 or was dependent on &#x003b1;5&#x003b2;1 integrin, CHO cells lacking (CHO B2) or expressing (CHO B2&#x003b1;27) the &#x003b1;5 integrin subunit were transfected with <italic>m</italic>Nrp1 and allowed to adhere to FN. Overexpression of <italic>m</italic>Nrp1 stimulated CHO cell adhesion to FN in the presence (CHO B2&#x003b1;27; <xref ref-type="fig" rid="pbio-1000025-g003">Figure 3</xref>A) but not in the absence (CHO B2; <xref ref-type="fig" rid="pbio-1000025-g003">Figure 3</xref>B) of &#x003b1;5&#x003b2;1 integrin. Therefore, Nrp1&#x02032;s proadhesive activity on FN is nonautonomous and mediated by &#x003b1;5&#x003b2;1 integrin.</p><fig id="pbio-1000025-g003" position="float"><label>Figure 3</label><caption><title>Nrp1 Regulation of Cell Adhesion to FN Requires &#x003b1;5&#x003b2;1 Integrin</title><p>(A,B) CHO cells expressing (CHO B2&#x003b1;27) (A) or lacking (CHO B2) (B) the &#x003b1;5 integrin subunit were transfected with <italic>m</italic>Nrp1 and allowed to adhere on FN. Overexpression of <italic>m</italic>Nrp1 stimulated CHO cell adhesion to FN in the presence but not in the absence of &#x003b1;5&#x003b2;1 integrin.</p><p>(C) Immunoprecipitation of endogenous <italic>h</italic>Nrp1 and &#x003b1;5&#x003b2;1 integrin from ECs preincubated for 10 min either in the absence or in the presence of 0.6 &#x003bc;M PMQ, followed, respectively, by Western blotting with anti-&#x003b1;5-integrin Ab and anti-Nrp1 Ab. In ECs, Nrp1 associates with &#x003b1;5&#x003b2;1 integrin, and the recycling inhibitor PMQ increases the stoichiometry of their interaction.</p><p>(D) NIH 3T3 fibroblasts were cotransfected with the GFP-tagged &#x003b1;5 integrin subunit or GFP alone together with an HA-tagged version of <italic>m</italic>Nrp1 full-length (<italic>m</italic>Nrp1) or <italic>m</italic>Nrp1dSEA or <italic>m</italic>Nrp1dCy deletion constructs. &#x003b1;5-GFP, but not GFP alone, coimmunoprecipitates with all HA-tagged <italic>m</italic>Nrp1 constructs.</p></caption><graphic xlink:href="pbio.1000025.g003"/></fig><p>We then examined whether in ECs Nrp1 could interact physically with &#x003b1;5&#x003b2;1 integrin. Lysates from ECs adhering on endogenous ECM were immunoprecipitated with an antibody (Ab) recognizing the FN receptor &#x003b1;5&#x003b2;1 and then blotted with anti-Nrp1 Ab. Nrp1 coimmunoprecipitated with &#x003b1;5&#x003b2;1, and blotting Nrp1 immunoprecipitates with anti-&#x003b1;5&#x003b2;1-integrin Ab further confirmed the association between endogenous <italic>h</italic>Nrp1 and &#x003b1;5&#x003b2;1 integrin in ECs (<xref ref-type="fig" rid="pbio-1000025-g003">Figure 3</xref>C). To better understand whether the Nrp1 cytoplasmic domain was required for the interaction with &#x003b1;5&#x003b2;1 integrin, lysates of NIH 3T3 fibroblasts overexpressing HA-tagged full-length or deletion constructs of <italic>m</italic>Nrp1 and green fluorescent protein (GFP)-tagged &#x003b1;5 integrin subunit (&#x003b1;5-GFP) &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b046">46</xref>&#x0005d; were immunoprecipitated with anti-GFP Ab and then blotted with anti-HA Ab (<xref ref-type="fig" rid="pbio-1000025-g003">Figure 3</xref>D). We found that both the C-terminal SEA and the cytoplasmic domain of Nrp1 were fully dispensable for its interaction with &#x003b1;5&#x003b2;1 integrin.</p><p>To understand the spatial and functional relationships between Nrp1 and &#x003b1;5&#x003b2;1 integrin in ECs, we first generated a monomeric red fluorescent protein (mRFP)-tagged <italic>m</italic>Nrp1 construct (<italic>m</italic>Nrp1-mRFP) that was then cotransfected with &#x003b1;5-GFP in ECs. Fluorescent confocal microscopy showed that at the plasma membrane of ECs adhering on FN <italic>m</italic>Nrp1-mRFP was enriched in close proximity to, or even tightly intermingled with, &#x003b1;5-GFP-containing adhesion sites (<xref ref-type="fig" rid="pbio-1000025-g004">Figure 4</xref>A, arrows). Moreover, <italic>m</italic>Nrp1-mRFP and &#x003b1;5-GFP fully colocalized in intracellular vesicles (<xref ref-type="fig" rid="pbio-1000025-g004">Figure 4</xref>A, arrowheads). Notably, immunofluorescence analysis of endogenous endothelial proteins confirmed the spatial links between <italic>h</italic>Nrp1 and vinculin (<xref ref-type="fig" rid="pbio-1000025-g004">Figure 4</xref>B) or &#x003b1;5&#x003b2;1 integrin (<xref ref-type="fig" rid="pbio-1000025-g004">Figure 4</xref>C) at either adhesion sites (<xref ref-type="fig" rid="pbio-1000025-g004">Figure 4</xref>B and <xref ref-type="fig" rid="pbio-1000025-g004">4</xref>C, arrows) or vesicular structures located in their proximity (<xref ref-type="fig" rid="pbio-1000025-g004">Figure 4</xref>C, arrowheads). The observation that Nrp1 and &#x003b1;5&#x003b2;1 colocalization was particularly apparent in intracellular vesicles indicated that these two molecules may associate at or near the point of endocytosis and that they may be internalized as a complex, which is then subsequently disassembled upon recycling to the plasma membrane. We have previously found that endosomal integrin complexes can be preserved by treating the cell with primaquine (PMQ), a receptor recycling inhibitor, prior to lysis &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b047">47</xref>&#x0005d;. Therefore, we immunoprecipitated &#x003b1;5&#x003b2;1 integrin or Nrp1 from cells that had been treated with PMQ for 10 min and probed for the presence of the &#x003b1;5&#x003b2;1/Nrp1 complex by Western blotting. Pretreatment of the cells with PMQ greatly increased the coprecipitation of &#x003b1;5&#x003b2;1 integrin with Nrp1 and vice versa (<xref ref-type="fig" rid="pbio-1000025-g003">Figure 3</xref>C), indicating the likelihood that this complex is more stable in endosomes than at the plasma membrane.</p><fig id="pbio-1000025-g004" position="float"><label>Figure 4</label><caption><title>Nrp1 Colocalizes with &#x003b1;5&#x003b2;1 Integrin at Adhesion Sites and Trafficking Vesicles</title><p>Fluorescent confocal microscopy analysis of untransfected or transfected ECs allowed to adhere for 3 h on FN.</p><p>(A) In transfected ECs, <italic>m</italic>Nrp1-mRFP (red) and &#x003b1;5-GFP (green) are in close association at adhesion sites (arrows) and colocalize in intracellular vesicles (arrowheads), as visible in merging (right panels).</p><p>(B) Immunofluorescence analysis reveals that both endogenous <italic>h</italic>Nrp1 and vinculin are enriched in adhesion sites of human ECs (arrows).</p><p>(C) Similar to what is observed with fluorescent protein-tagged constructs, immunofluorescence analysis showed that endogenous <italic>h</italic>Nrp1 and &#x003b1;5&#x003b2;1 integrin closely associate in adhesion sites (arrows) and colocalize in intracellular vesicles (arrowheads). Lower panels are magnifications of the indicated boxed areas.</p><p>White bar in (A) corresponds to 25 &#x003bc;m.</p></caption><graphic xlink:href="pbio.1000025.g004"/></fig><p>To further characterize the interaction between Nrp1 and &#x003b1;5&#x003b2;1 integrin, we measured fluorescence resonance energy transfer (FRET) in live NIH 3T3 cells transfected with &#x003b1;5-GFP alone or cotransfected with &#x003b1;5-GFP and <italic>m</italic>Nrp1 tagged with the fluorescent protein Cherry, an improved version of mRFP (<italic>m</italic>Nrp1-Cherry). Total internal reflection fluorescence (TIRF) illumination &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b048">48</xref>&#x0005d; was used to selectively excite &#x003b1;5-GFP at the basal cell plasma membrane where ECM adhesions lie. Fluorescence resonance energy transfer was measured by fluorescence lifetime imaging microscopy (FLIM) &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b049">49</xref>&#x0005d; and was read out as a decrease in donor (GFP) fluorescence lifetime. We found that the &#x003b1;5-GFP fluorescence lifetime was significantly reduced in cells that coexpressed <italic>m</italic>Nrp1-Cherry, indicating that FRET, and thus a close physical interaction, was occurring between &#x003b1;5&#x003b2;1 and Nrp1 at adhesion sites with an 11.5&#x00025; FRET efficiency (<xref ref-type="fig" rid="pbio-1000025-g005">Figure 5</xref>).</p><fig id="pbio-1000025-g005" position="float"><label>Figure 5</label><caption><title>TIRF/FLIM Analysis of the Fluorescence Resonance Energy Transfer between &#x003b1;5-GFP and <italic>m</italic>Nrp1-Cherry</title><p>NIH 3T3 fibroblasts were transfected with either &#x003b1;5-GFP alone (A,B) or cotransfected with &#x003b1;5-GFP and <italic>m</italic>Nrp1-Cherry (C,D) and plated onto FN-coated glass-bottom dishes.</p><p>(A,C) Fluorescent intensity images of &#x003b1;5-GFP excited in TIRF with a 473-nm laser show the expected &#x003b1;5-GFP localization in adhesion sites.</p><p>(B,D) Pseudocolor images of the spatial distribution of donor (&#x003b1;5-GFP) fluorescence lifetimes &#x003c4; (measured in nanoseconds) were obtained by frequency-domain FLIM analysis of TIRF fluorescence images shown in (A) and (C).</p><p>(E) In comparison with cells transfected with &#x003b1;5-GFP alone (<italic>n</italic> &#x0003d; 7), the donor lifetime &#x003c4; is decreased (from 2.6 &#x000b1; 0.05 to 2.3 &#x000b1; 0.06 ns) in adhesion sites of cells expressing both &#x003b1;5-GFP and <italic>m</italic>Nrp1-Cherry (<italic>n</italic> &#x0003d; 7; <italic>P</italic> &#x0003d; 0.00000005).</p></caption><graphic xlink:href="pbio.1000025.g005"/></fig><p>Taken together, these data indicate that in living cells Nrp1 physically associates with &#x003b1;5&#x003b2;1 at or near sites of cell&#x02013;ECM contact and that this interaction is likely maintained following internalization of the complex.</p></sec><sec id="s2d"><title>Nrp1 Controls the Traffic of Active &#x003b1;5&#x003b2;1 Integrin</title><p>The efficiency of cell adhesion and spreading on ECM is generally thought to be proportional to the amount of either active or total (i.e., active and inactive) integrin at the cell surface &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b001">1</xref>,<xref ref-type="bibr" rid="pbio-1000025-b006">6</xref>&#x0005d;. We found that lack of Nrp1 did not alter the global amount of either total (<xref ref-type="fig" rid="pbio-1000025-g001">Figure 1</xref>A), as already reported &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b031">31</xref>&#x0005d;, or active &#x003b1;5&#x003b2;1 integrin, as recognized by the mouse monoclonal Ab (mAb) SNAKA51 &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b045">45</xref>&#x0005d; (<xref ref-type="supplementary-material" rid="pbio-1000025-sg003">Figure S3</xref>). Then, we analyzed whether Nrp1 could influence the amount of &#x003b1;5&#x003b2;1 integrin on the endothelial surface. Biotinylation experiments revealed that knocking down human Nrp1 did not diminish the surface levels of either total or active &#x003b1;5&#x003b2;1 integrin in si<italic>h</italic>Nrp1 ECs (<xref ref-type="fig" rid="pbio-1000025-g006">Figure 6</xref>A), thus suggesting that a mechanism alternative to the control of integrin conformation should be responsible for Nrp1-dependent activation of &#x003b1;5&#x003b2;1 integrin function in ECs.</p><fig id="pbio-1000025-g006" position="float"><label>Figure 6</label><caption><title>Nrp1 Regulates the Traffic of Active &#x003b1;5&#x003b2;1 Integrin in ECs</title><p>(A) Time-course assays reveal an impairment of active but not total &#x003b1;5&#x003b2;1 integrin internalization in ECs silenced for <italic>h</italic>Nrp1 (si<italic>h</italic>N1) in comparison with cells transfected with control siRNA (siCtl).</p><p>(B,C) Relative quantifications of time-course internalization assays shown in (A) of total (B) and active (C) &#x003b1;5&#x003b2;1 integrin are depicted.</p><p>(D) Wild-type <italic>m</italic>Nrp1, but neither <italic>m</italic>Nrp1dSEA nor <italic>m</italic>Nrp1dCy deletion constructs, was able to rescue the early (4 min) internalization defects of active &#x003b1;5&#x003b2;1 integrin in si<italic>h</italic>Nrp1 ECs as quantified in the lower histogram.</p></caption><graphic xlink:href="pbio.1000025.g006"/></fig><p>On the basis of our observations that Nrp1 and &#x003b1;5&#x003b2;1 integrin colocalize in intracellular vesicles (<xref ref-type="fig" rid="pbio-1000025-g004">Figure 4</xref>A and <xref ref-type="fig" rid="pbio-1000025-g004">4</xref>C) and that inhibition of recycling by PMQ increased the association of Nrp1 with &#x003b1;5&#x003b2;1 integrin (<xref ref-type="fig" rid="pbio-1000025-g003">Figure 3</xref>C), we decided to monitor the effect of Nrp1 knockdown on the internalization of total and active surface &#x003b1;5&#x003b2;1 integrin. Endothelial cells were surface-labeled with cleavable biotin at 4 &#x000b0;C and incubated at 37 &#x000b0;C for different times to allow internalization, and then biotin remaining on cell-surface proteins was cleaved at 4 &#x000b0;C &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b050">50</xref>&#x0005d;. Integrin internalization was quantified by immunoprecipitation of either total (<xref ref-type="fig" rid="pbio-1000025-g006">Figure 6</xref>A and <xref ref-type="fig" rid="pbio-1000025-g006">6</xref>B) or active (<xref ref-type="fig" rid="pbio-1000025-g006">Figure 6</xref>A and <xref ref-type="fig" rid="pbio-1000025-g006">6</xref>C) &#x003b1;5&#x003b2;1 integrin, followed by Western blot analysis with streptavidin. Notably, although endocytosis of the cell-surface pool of total &#x003b1;5&#x003b2;1 integrin (i.e., active plus inactive heterodimers) was not detectably altered in si<italic>h</italic>Nrp1 cells (<xref ref-type="fig" rid="pbio-1000025-g006">Figure 6</xref>A and <xref ref-type="fig" rid="pbio-1000025-g006">6</xref>B), knockdown of Nrp1 markedly reduced the quantity of active (SNAKA51-positive) &#x003b1;5&#x003b2;1 heterodimers internalized by ECs (<xref ref-type="fig" rid="pbio-1000025-g006">Figure 6</xref>A and <xref ref-type="fig" rid="pbio-1000025-g006">6</xref>C). Taken together, these data indicate that on the cell surface Nrp1 interacts with active &#x003b1;5&#x003b2;1 heterodimers at adhesion sites (<xref ref-type="fig" rid="pbio-1000025-g004">Figure 4</xref>A and <xref ref-type="fig" rid="pbio-1000025-g004">4</xref>C, arrows) and acts to promote their internalization and localization to intracellular vesicles (<xref ref-type="fig" rid="pbio-1000025-g004">Figure 4</xref>A and <xref ref-type="fig" rid="pbio-1000025-g004">4</xref>C, arrowheads).</p><p>To visualize the internalization and postendocytic trafficking of the &#x003b1;5&#x003b2;1/Nrp1 complex, we deployed the photoactivatable (PA) &#x003b1;5-GFP (&#x003b1;5-PA-GFP) probe that we had previously used to monitor &#x003b1;5&#x003b2;1 trafficking in human ovarian carcinoma A2780 cells &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b051">51</xref>&#x0005d;. However, the multitude of fluorescent vesicles travelling to and from the cell surface made it difficult to track the progress of individual &#x003b1;5&#x003b2;1 integrin transport vesicles. Therefore, we used TIRF to restrict the plane of activating fluorescence, such that only &#x003b1;5-PA-GFP present at or near the cell surface became photoactivated. Then we tracked the movement of this photoactivated fraction of &#x003b1;5&#x003b2;1 integrin using time-lapse epifluorecence microscopy. With this novel technique, &#x003b1;5&#x003b2;1 integrin was photoactivated almost exclusively at adhesion sites (mostly fibrillar adhesions), where it colocalized with <italic>m</italic>Nrp1-Cherry (<xref ref-type="fig" rid="pbio-1000025-g007">Figure 7</xref>, arrows). Photoactivated &#x003b1;5&#x003b2;1 was then rapidly (&#x0003c;6 s) internalized and cotransported with <italic>m</italic>Nrp1-Cherry in small endocytic vesicles (<xref ref-type="fig" rid="pbio-1000025-g007">Figure 7</xref>, empty arrowheads, and <xref ref-type="supplementary-material" rid="pbio-1000025-sv001">Video S1</xref>) that moved away from the fibrillar adhesions. In addition, we found that &#x003b1;5&#x003b2;1 integrin turnover in ECM adhesions was unexpectedly very rapid (<xref ref-type="supplementary-material" rid="pbio-1000025-sg004">Figure S4</xref> and <xref ref-type="supplementary-material" rid="pbio-1000025-sv002">Video S2</xref>), with the &#x003b1;5-PA-GFP signal leaving the adhesive sites, accumulating in vesicles, and disappearing by &#x0223c;45 s after photoactivation in approximately 50&#x00025; of the adhesion sites and by &#x0223c;115 s in the remaining ones (<xref ref-type="supplementary-material" rid="pbio-1000025-sv002">Video S2</xref>).</p><fig id="pbio-1000025-g007" position="float"><label>Figure 7</label><caption><title>Rapid Turnover of &#x003b1;5&#x003b2;1 Integrin from Adhesion Sites into Nrp1-Positive Vesicles</title><p>A representative NIH 3T3 cell was cotransfected with <italic>m</italic>Nrp1-Cherry and &#x003b1;5-PA-GFP, photoactivated in TIRF, and observed in time-lapse epifluorescence microscopy. After photoactivation, &#x003b1;5-PA-GFP integrin (left panels) was found in elongated adhesive structures (i.e., fibrillar adhesions; arrows), where it colocalized with <italic>m</italic>Nrp1-Cherry (middle panels), as evident in merged images as well (right panels). &#x003b1;5-PA-GFP integrin is also present in nascent vesicles near adhesive structures (arrowheads). Over time GFP fluorescence intensity (left panels) is constant in some vesicles (solid arrowheads), while it increases in others (empty arrowheads), that become progressively enriched in &#x003b1;5-PA-GFP integrin deriving from membrane adhesion sites. <italic>m</italic>Nrp1-Cherry (middle panels) is also present in the same vesicles (solid and empty arrowheads), as visible in merged images (right panels). At each time point, lower panels are magnifications of the corresponding upper panels (see also <xref ref-type="supplementary-material" rid="pbio-1000025-sv001">Video S1</xref>).</p></caption><graphic xlink:href="pbio.1000025.g007"/></fig><p>Having established that &#x003b1;5&#x003b2;1 integrin and Nrp1 are cointernalized at fibrillar adhesions, we wished to determine whether the integrin was then recycled from Nrp1-positive vesicles back to the plasma membrane. To address this, we aimed a pulse of 405-nm laser light at a &#x0201c;single point&#x0201d; corresponding to Nrp1-positive vesicles, leading to the immediate photoactivation of &#x003b1;5-PA-GFP integrin largely within the confines of these structures (<xref ref-type="fig" rid="pbio-1000025-g008">Figure 8</xref> and <xref ref-type="supplementary-material" rid="pbio-1000025-sv003">Video S3</xref>). During the following 80 s, fluorescence was lost from the photoactivated vesicle, and this was accompanied by a corresponding increase in integrin fluorescence at peripheral elongated structures that look like adhesion sites (<xref ref-type="fig" rid="pbio-1000025-g008">Figure 8</xref>, red circle and white arrows). On the contrary, when the activating laser was aimed at a cell region devoid of Nrp1-positive vesicles, little or no photoactivation occurred (<xref ref-type="supplementary-material" rid="pbio-1000025-sg005">Figure S5</xref> and <xref ref-type="supplementary-material" rid="pbio-1000025-sv004">Video S4</xref>), indicating that the &#x003b1;5-PA-GFP fluorescence detected in <xref ref-type="fig" rid="pbio-1000025-g008">Figure 8</xref> was indeed at <italic>m</italic>Nrp1-Cherry vesicles and not at the plasma membrane above and below them.</p><fig id="pbio-1000025-g008" position="float"><label>Figure 8</label><caption><title>Upon Photoactivation in <italic>m</italic>Nrp1-Cherry-Positive Vesicles, &#x003b1;5-PA-GFP Recycles Back to Membrane Adhesions</title><p>NIH 3T3 cells were cotransfected with <italic>m</italic>Nrp1-Cherry and &#x003b1;5-PA-GFP. &#x003b1;5-PA-GFP was then locally photoactivated in vesicles containing <italic>m</italic>Nrp1-Cherry (blue circle) and followed by time-lapse confocal microscopy. Fluorescence intensity was measured over time in Nrp1-positive vesicles (blue circle) and at the plasma membrane (red circle). The time-lapse plot (lower panel) shows that the &#x003b1;5-PA-GFP fluorescence intensity decreases in the vesicles, while it increases at the plasma membrane. This means that &#x003b1;5-PA-GFP integrin is recycled from Nrp1-containing vesicles to the plasma membrane, where it appears to be enriched in what looks like adhesive structures (red circle and white arrows) (see also <xref ref-type="supplementary-material" rid="pbio-1000025-sv003">Video S3</xref>).</p></caption><graphic xlink:href="pbio.1000025.g008"/></fig><p>Taken together, these data indicate that &#x003b1;5&#x003b2;1 integrin and Nrp1 are cointernalized into intracellular vesicles, which are then rapidly returned or recycled to the plasma membrane. Interestingly, both the internalization and the recycling of Nrp1-associated &#x003b1;5&#x003b2;1 integrin occur at the site of adhesion to the ECM.</p></sec><sec id="s2e"><title>Cytoplasmic Domain of Nrp1 Elicits the Endocytosis of Active &#x003b1;5&#x003b2;1 Integrin via GIPC1 in ECs</title><p>In the eukaryotic early endocytic pathway, the small GTPase Rab5 is a rate-limiting component that regulates the entry of cargoes from the plasma membrane into the early endosome &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b052">52</xref>&#x0005d;. Hence, we analyzed the early endocytic steps of active &#x003b1;5&#x003b2;1 integrin in ECs cotransfected with <italic>m</italic>Nrp1-mRFP and Rab5-GFP, which were incubated with the &#x003b1;5&#x003b2;1 integrin activation reporter mAb SNAKA51 for 30 min at 4 &#x000b0;C and then at 37 &#x000b0;C for different time points. Fluorescent confocal analysis indicated that, after 1&#x02013;3 min of internalization at 37 &#x000b0;C, Nrp1 and active &#x003b1;5&#x003b2;1 integrin colocalized in early Rab5-positive vesicles near the EC plasma membrane (<xref ref-type="fig" rid="pbio-1000025-g009">Figure 9</xref>A). Accordingly, immunofluorescence analysis of endogenous endothelial proteins confirmed that <italic>h</italic>Nrp1 and Rab5 colocalized in vesicles, many of which were located near adhesion sites (<xref ref-type="fig" rid="pbio-1000025-g009">Figure 9</xref>B, empty arrowheads), further supporting the view that Nrp1 can induce &#x003b1;5&#x003b2;1-mediated adhesion by promoting the preferential internalization of its active conformation into Rab5-positive early endosomes and the ensuing recycling to newly forming cell&#x02013;ECM contacts.</p><fig id="pbio-1000025-g009" position="float"><label>Figure 9</label><caption><title>Nrp1 and Active &#x003b1;5&#x003b2;1 Integrin Localize into Rab5-Positive Early Endosomes</title><p>(A) Fluorescent confocal microscopy analysis of ECs transfected with <italic>m</italic>Nrp1-mRFP and Rab5-GFP and then incubated with the anti-active-&#x003b1;5&#x003b2;1 mAb (SNAKA51). <italic>m</italic>Nrp1-mRFP and active &#x003b1;5&#x003b2;1 colocalize into Rab5-GFP-positive early endosomes as shown in merging (arrowheads). Lower panels are magnifications of the boxed areas shown in the upper panels.</p><p>(B) Immunofluorescent confocal microscopy analysis of endogenous <italic>h</italic>Nrp1 and Rab5 localization in ECs. As described previously, <italic>h</italic>Nrp1 is concentrated in elongated adhesion sites and in vesicular structures. Endogenous Rab5 colocalizes with <italic>h</italic>Nrp1 into early endosomes (solid and empty arrowheads), many of which are located near adhesion sites (empty arrowheads). Lower-right panels are magnifications of the boxed areas shown in the other panels.</p><p>White bar in (A) corresponds to 25 &#x003bc;m.</p></caption><graphic xlink:href="pbio.1000025.g009"/></fig><p>Next, to characterize the molecular mechanisms by which Nrp1 regulates the traffic of active &#x003b1;5&#x003b2;1 integrin, we evaluated the abilities of <italic>m</italic>Nrp1 full-length and mutant constructs to rescue the integrin internalization defects that we observed in si<italic>h</italic>Nrp1 ECs. Remarkably, only wild-type <italic>m</italic>Nrp1, but neither <italic>m</italic>Nrp1dSEA nor <italic>m</italic>Nrp1dCy construct, was able to rescue the si<italic>h</italic>Nrp1 EC defects in the endocytosis of active &#x003b1;5&#x003b2;1 integrin (<xref ref-type="fig" rid="pbio-1000025-g006">Figure 6</xref>D). Therefore, in ECs the SEA motif of Nrp1, which binds the endocytic adaptor GIPC1 &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b036">36</xref>&#x0005d;, is mandatory for Nrp1 stimulation of cell adhesion to FN (<xref ref-type="fig" rid="pbio-1000025-g002">Figure 2</xref>C), endogenous FN fibrillogenesis (<xref ref-type="fig" rid="pbio-1000025-g002">Figure 2</xref>D&#x02013;F), and active &#x003b1;5&#x003b2;1 integrin endocytosis (<xref ref-type="fig" rid="pbio-1000025-g006">Figure 6</xref>D).</p><p>The N-terminal portion of GIPC1 mediates its oligomerization, whereas its central PDZ domain can bind the C-terminal consensus S/T-X-&#x003a6; sequence of Nrp1 &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b036">36</xref>&#x0005d;, the &#x003b1;5 integrin subunit &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b053">53</xref>&#x0005d;, and the Rab5/Rab21 interactor protein APPL1 &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b054">54</xref>,<xref ref-type="bibr" rid="pbio-1000025-b055">55</xref>&#x0005d;. Thus, we theorized that as a result GIPC1 could support the Rab5-dependent early internalization of &#x003b1;5&#x003b2;1 integrin. To test this hypothesis, we silenced the expression of GIPC1 in human umbilical artery ECs by RNAi and examined its effect on &#x003b1;5&#x003b2;1 integrin traffic. Western blot analysis showed that, 96 h after the second transfection, GIPC1 protein, but not &#x003b2;-tubulin, was successfully silenced in si<italic>h</italic>GIPC1 ECs in comparison with control cells (<xref ref-type="fig" rid="pbio-1000025-g010">Figure 10</xref>A). Knockdown of GIPC1 in ECs dramatically reduced the amount of internalized total (<xref ref-type="fig" rid="pbio-1000025-g010">Figure 10</xref>C and <xref ref-type="fig" rid="pbio-1000025-g010">10</xref>D) and active (<xref ref-type="fig" rid="pbio-1000025-g010">Figure 10</xref>C and <xref ref-type="fig" rid="pbio-1000025-g010">10</xref>E) &#x003b1;5&#x003b2;1 integrin by &#x0223c;70&#x00025; throughout the whole internalization assay, suggesting that indeed the interaction of &#x003b1;5&#x003b2;1 integrin with GIPC1 is crucial for the endocytosis and the proper functioning of this integrin. Accordingly, short-term adhesion assays showed that, in comparison with control cells, si<italic>h</italic>GIPC1 ECs adhered poorly to FN (<xref ref-type="fig" rid="pbio-1000025-g010">Figure 10</xref>B) and much less efficiently assembled endogenous sFN into a fibrillar network (<xref ref-type="supplementary-material" rid="pbio-1000025-sg001">Figure S1</xref>H) in comparison with cells transfected with siCtl (<xref ref-type="supplementary-material" rid="pbio-1000025-sg001">Figure S1</xref>G). The latter defect was not due to a reduction in FN mRNA or protein levels as demonstrated by real-time RT-PCR (<xref ref-type="supplementary-material" rid="pbio-1000025-sg001">Figure S1</xref>B) and Western blotting (<xref ref-type="supplementary-material" rid="pbio-1000025-sg001">Figure S1</xref>E). Hence, within Nrp1 the extracellular domain mediates the association with &#x003b1;5&#x003b2;1 integrin, and the C-terminal SEA sequence allows the binding to the endocytic adaptor GIPC1 that stimulates the internalization and traffic of active &#x003b1;5&#x003b2;1 integrin, finally promoting EC adhesion to FN and FN fibrillogenesis.</p><fig id="pbio-1000025-g010" position="float"><label>Figure 10</label><caption><title>In ECs GIPC1 and Myo6 Regulate &#x003b1;5&#x003b2;1 Integrin Traffic and Function</title><p>(A) Western blot analysis of protein expression in ECs silenced for human GIPC1 (si<italic>h</italic>GIPC1) or Myo6 (si<italic>h</italic>Myo6) or transfected with control siRNA (siCtl) reveals an efficient silencing of GIPC1 or Myo6 at 96 h after the second oligofection.</p><p>(B) Comparison between siCtl (black) and either si<italic>h</italic>GIPC1 (red) or si<italic>h</italic>Myo6 (green) transfected ECs adhering to FN.</p><p>(C) Time-course analysis reveals an impairment of both total and active &#x003b1;5&#x003b2;1 integrin internalization in ECs silenced for <italic>h</italic>GIPC1 in comparison with control cells (siCtl).</p><p>(D,E) Relative quantification of time-lapse endocytosis assay (shown in (C)) of total (D) or active (E) &#x003b1;5&#x003b2;1 integrin in ECs silenced for <italic>h</italic>GIPC1.</p><p>(F) Time-course analysis reveals a significant impairment of active but not total &#x003b1;5&#x003b2;1 integrin internalization in ECs silenced for <italic>h</italic>Myo6 in comparison with control cells (siCtl).</p><p>(G,H) Relative quantification of time-course endocytosis assay (shown in (F)) of total (G) or active (H) &#x003b1;5&#x003b2;1 integrin in ECs silenced for <italic>h</italic>Myo6.</p></caption><graphic xlink:href="pbio.1000025.g010"/></fig></sec><sec id="s2f"><title>GIPC1 Interacting Motor Myo6 Promotes Active &#x003b1;5&#x003b2;1 Endocytosis, EC Adhesion to FN, and <italic>FN1</italic> Gene Transcription</title><p>Because the C terminus of GIPC1 binds to the minus-end-directed motor myosin VI (Myo6) that has also been involved in endocytosis &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b056">56</xref>&#x0005d;, we considered the hypothesis that Myo6 could cooperate with GIPC1 in promoting &#x003b1;5&#x003b2;1 integrin internalization. Interestingly, RNAi-mediated knockdown of Myo6 in human umbilical artery ECs (<xref ref-type="fig" rid="pbio-1000025-g010">Figure 10</xref>A) resulted in a significant (&#x0223c;70&#x00025;) impairment of active &#x003b1;5&#x003b2;1 integrin internalization (<xref ref-type="fig" rid="pbio-1000025-g010">Figure 10</xref>F and <xref ref-type="fig" rid="pbio-1000025-g010">10</xref>H), whereas the total integrin pool was only mildly affected (&#x0223c;25&#x00025;; <xref ref-type="fig" rid="pbio-1000025-g010">Figure 10</xref>F and <xref ref-type="fig" rid="pbio-1000025-g010">10</xref>G). These data, together with the fact that si<italic>h</italic>Myo6 EC adhesion to FN was severely hampered (<xref ref-type="fig" rid="pbio-1000025-g010">Figure 10</xref>B), indicate that Myo6 cooperates with GIPC1 in the regulation of active &#x003b1;5&#x003b2;1 integrin endocytosis.</p><p>Similarly to what we noticed after Nrp1 and GIPC1 knockdown, ECs in which Myo6 was silenced did not efficiently assemble an endogenous FN fibrillar network (<xref ref-type="supplementary-material" rid="pbio-1000025-sg001">Figure S1</xref>I) in comparison with cells transfected with siCtl (<xref ref-type="supplementary-material" rid="pbio-1000025-sg001">Figure S1</xref>G). However, differently from what we observed in si<italic>h</italic>Nrp1 and si<italic>h</italic>GIPC1 ECs, the endogenous FN fibrillogenesis defect seen in si<italic>h</italic>Myo6 ECs was due to an inhibition of <italic>FN1</italic> gene transcription mRNA (<xref ref-type="supplementary-material" rid="pbio-1000025-sg001">Figure S1</xref>C), which associated to a significant reduction of FN protein levels as well (<xref ref-type="supplementary-material" rid="pbio-1000025-sg001">Figure S1</xref>F). Indeed, in addition to its role in cytoplasmic transporting and anchoring, Myo6 is also present in the nucleus, where it promotes the RNA-polymerase-II-dependent transcription of active genes &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b057">57</xref>&#x0005d;. Here we identify the <italic>FN1</italic> gene as a new Myo6 transcriptional target and downstream effector that can bolster EC adhesion and motility.</p></sec></sec><sec id="s3"><title>Discussion</title><p>Defects of developing blood vessels caused by <italic>Nrp1</italic> gene knockdown in mice &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b023">23</xref>,<xref ref-type="bibr" rid="pbio-1000025-b024">24</xref>&#x0005d; are different from vascular malformations displayed by mice lacking either SEMA3A &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b016">16</xref>&#x0005d; or VEGF-A165 (<italic>Vegf-a<sup>120/120</sup></italic> mice) &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b026">26</xref>&#x0005d;. Furthermore, it has been recently reported that Nrp1 is required for EC responses to both VEGF-A165 and VEGF-A121 isoforms, the latter being incapable of binding Nrp1 on the EC surface &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b058">58</xref>,<xref ref-type="bibr" rid="pbio-1000025-b059">59</xref>&#x0005d;. Therefore, it is conceivable that the vascular abnormalities of <italic>Nrp1<sup>&#x02013;/&#x02013;</sup></italic> mice could be due at least in part to the disruption of a VEGF-A165/SEMA3A-independent Nrp1 function. &#x003b1;5&#x003b2;1 Integrin and its ligand FN are key players in vascular development &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b003">3</xref>&#x0005d;. The data reported here support a model in which Nrp1, through its cytoplasmic domain and independently of its activity as a SEMA3A and VEGF-A165 coreceptor, stimulates GIPC1/Myo6-dependent endocytosis and traffic of active &#x003b1;5&#x003b2;1 integrin, thus promoting EC adhesion to FN and FN fibrillogenesis.</p><p>In rescue experiments, where we reintroduced full-length and mutant murine Nrp1 constructs in human ECs in which endogenous <italic>h</italic>Nrp1 was simultaneously knocked down by RNAi, we showed that EC adhesion to FN and polymerization of endogenous sFN into fibrils depend on the cytoplasmic domain of Nrp1, the C-terminal SEA motif representing the minimal sequence required to exert these functions. Importantly, as already shown for SEMA3A-elicited growth cone collapse in neurons &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b022">22</xref>&#x0005d;, we found that the cytoplasmic domain of Nrp1 is instead dispensable for VEGF-A165 stimulation and SEMA3A inhibition of EC adhesion to FN. Moreover, by using two CHO cell clones differing in the expression of &#x003b1;5&#x003b2;1 integrin, we demonstrated that Nrp1 alone does not directly mediate adhesion to FN and that it requires &#x003b1;5&#x003b2;1 integrin. Therefore, we conclude that in ECs, independently of VEGF-A165 and SEMA3A, Nrp1 stimulates &#x003b1;5&#x003b2;1-mediated adhesion to FN and endogenous FN fibrillogenesis via its cytoplasmic SEA motif &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b036">36</xref>&#x0005d;. This motif, similar to the C-terminal SDA sequence of the &#x003b1;5 integrin subunit &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b053">53</xref>&#x0005d;, selectively and specifically binds the PDZ domain of the homomultimeric endocytic adaptor GIPC1.</p><p>It is known that conformational activation of cell-surface integrins supports cell adhesion and spreading, whereas transition of integrins toward an inactive bent conformation causes cell de-adhesion and rounding up &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b001">1</xref>,<xref ref-type="bibr" rid="pbio-1000025-b060">60</xref>,<xref ref-type="bibr" rid="pbio-1000025-b061">61</xref>&#x0005d;. However, we observed that lack of Nrp1 does not result in the reduction of either active or total &#x003b1;5&#x003b2;1 integrin either at the cell surface or intracellularly. Rather, by combining biochemical analysis with conventional and TIRF/FLIM confocal microscopy, we found that at the plasma membrane Nrp1 is tightly associated with adhesion sites, where it physically interacts with &#x003b1;5&#x003b2;1 integrin. The complex formed between active &#x003b1;5&#x003b2;1 integrin and Nrp1 is then rapidly internalized into Rab5-positive endosomes in an Nrp1-dependent fashion. Interestingly, the integrin is then returned to the plasma membrane from Nrp1-containing vesicles, and this recycling event appears to be targeted to adhesive structures. In addition, although the extracellular domain of Nrp1 is sufficient for its interaction with &#x003b1;5&#x003b2;1 integrin, the C-terminal GIPC1-binding SEA sequence of Nrp1 is necessary for stimulating EC adhesion to FN. Accordingly, knocking down either GIPC1 or its interacting motor Myo6 results in a significant impairment of active &#x003b1;5&#x003b2;1 integrin endocytosis and EC adhesion to FN.</p><p>Taken together, our data indicate that, during EC adhesion and spreading on FN, Nrp1, through its extracellular domain, transiently interacts with active &#x003b1;5&#x003b2;1 integrin at adhesive sites and, via its cytoplasmic association with GIPC1, enhances the early endocytosis and the ensuing recycling of active &#x003b1;5&#x003b2;1 integrin to newly forming adhesion sites (<xref ref-type="fig" rid="pbio-1000025-g011">Figure 11</xref>A). It is therefore likely that fast cycles of endocytosis from and recycling to ECM adhesions of active &#x003b1;5&#x003b2;1 integrin could allow real-time optimization of adhesion during EC spreading on FN. These conclusions are in line with the recent findings by Ivaska and colleagues &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b008">8</xref>,<xref ref-type="bibr" rid="pbio-1000025-b009">9</xref>&#x0005d; that found how endocytosis of &#x003b2;1 integrins, in addition to their established role in directional migration &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b007">7</xref>&#x0005d;, regulates cell adhesion and spreading as well. In particular, they reported that class V Rab GTPases (for review, see &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b052">52</xref>&#x0005d;) Rab21 and Rab5 directly bind to several integrin &#x003b1; subunits, &#x003b1;5 included, by interacting with the conserved membrane proximal region GFFKR, which interestingly has been previously implicated in conformational integrin activation &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b061">61</xref>&#x0005d;. It is thus conceivable that GIPC1 oligomers could favor &#x003b1;5&#x003b2;1 integrin endocytosis by bridging the &#x003b1;5 integrin subunit and the Rab5/Rab21 interactor APPL1, finally stabilizing the interaction between these small GTPases and &#x003b1;5&#x003b2;1 integrin. This could represent a main functional feature distinguishing &#x003b1;5&#x003b2;1 from other integrin heterodimers not interacting with GIPC1. Finally, the fact that by 2 min after activation &#x003b1;5-PA-GFP disappeared from preexisting adhesion sites into vesicles without a concomitant cell retraction suggests the existence of a steady endo-exocytic flow of (active) &#x003b1;5&#x003b2;1 integrins from and toward existing ECM adhesions as well (<xref ref-type="fig" rid="pbio-1000025-g011">Figure 11</xref>B). This mechanism could allow adherent cells to be always ready to rapidly exchange integrins among cell&#x02013;ECM contacts in response to extracellular stimuli. Such a scenario is also compatible with a previous study by Ezratty and colleagues &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b062">62</xref>&#x0005d; and implies that disassembly of ECM adhesions could depend on an imbalance of endocytosis over recycling.</p><fig id="pbio-1000025-g011" position="float"><label>Figure 11</label><caption><title>Model for Nrp1 Regulation of &#x003b1;5&#x003b2;1 Integrin Traffic and Function in ECs</title><p>(A) At adhesive sites of ECs spreading on FN, Nrp1, via its cytoplasmic association with oligomers of the endocytic adaptor GIPC1, promotes the Rab5/Rab21-dependent internalization of active &#x003b1;5&#x003b2;1 integrin. Once endocytosed, active &#x003b1;5&#x003b2;1 is then recycled back from Nrp1-positive vesicles to the cell surface, thus favoring the dynamic rehandling of newly forming adhesion sites. GIPC1 oligomers could facilitate the association of the &#x003b1;5 integrin subunit with the Bin-Amphiphysin-Rvs (BAR) protein and Rab5/Rab21 interactor APPL1. Myo6 associates with and assists GIPC1 in promoting active &#x003b1;5&#x003b2;1 endocytosis and the ensuing postendocytic traffic.</p><p>(B) Moreover, in adherent cells a steady endo-exocytic flow of (active) &#x003b1;5&#x003b2;1 integrins from and toward existing ECM adhesions could allow cells to rapidly adjust polarity and cell&#x02013;ECM contacts in response to extracellular stimuli.</p><p>(C) In addition, Myo6 can translocate to the EC nucleus, where it stimulates the RNA-polymerase-II-dependent transcription of the <italic>FN1</italic> gene.</p></caption><graphic xlink:href="pbio.1000025.g011"/></fig><p>Our observation that Myo6 siRNA severely impairs EC adhesion to FN and results in a significant reduction in the internalization of active &#x003b1;5&#x003b2;1 integrin suggests that Myo6 cooperates with GIPC1 (<xref ref-type="fig" rid="pbio-1000025-g011">Figure 11</xref>A and <xref ref-type="fig" rid="pbio-1000025-g011">11</xref>B) and is compatible with the notion that Myo6 plays a role in the formation and transport of endocytic vesicles along F-actin microfilaments &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b056">56</xref>&#x0005d;. The decrease in FN mRNA that we noticed in si<italic>h</italic>Myo6 ECs is likely due to the lack of the transcriptional activity displayed by Myo6 in the nucleus &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b057">57</xref>&#x0005d; that could depend on a still not fully characterized actin&#x02013;myosin-based mechanism of transcription &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b063">63</xref>,<xref ref-type="bibr" rid="pbio-1000025-b064">64</xref>&#x0005d;. Therefore, Myo6 can support EC adhesion and motility by promoting both active &#x003b1;5&#x003b2;1 integrin traffic (<xref ref-type="fig" rid="pbio-1000025-g011">Figure 11</xref>A and <xref ref-type="fig" rid="pbio-1000025-g011">11</xref>B) and <italic>FN1</italic> gene transcription (<xref ref-type="fig" rid="pbio-1000025-g011">Figure 11</xref>C). Additionally, these findings can have significant implications for the biology of &#x003b1;5&#x003b2;1-expressing human carcinomas &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b051">51</xref>,<xref ref-type="bibr" rid="pbio-1000025-b065">65</xref>&#x0005d;, in which Myo6 can be overexpressed and promote metastatic invasion &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b066">66</xref>&#x02013;<xref ref-type="bibr" rid="pbio-1000025-b068">68</xref>&#x0005d;.</p><p>In conclusion, we propose here that Nrp1, in addition to and independently of its role as coreceptor for VEGF-A165 and SEMA3A, stimulates through its cytoplasmic domain the spreading of ECs on FN by increasing the Rab5/GIPC1/Myo6-dependent internalization of active &#x003b1;5&#x003b2;1 integrin. Nrp1 modulation of &#x003b1;5&#x003b2;1-mediated adhesion can play a causal role in the generation of angiogenesis defects observed in <italic>Nrp1</italic> null mice. We anticipate that signaling pathways controlling Nrp1 expression in ECs could ultimately modulate the activity of &#x003b1;5&#x003b2;1 integrin. In particular, Nrp1 is a major target of the inhibitory Delta-like 4&#x02013;Notch signaling pathway &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b069">69</xref>&#x0005d; that negatively regulates the formation of endothelial tip cells &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b010">10</xref>&#x0005d;. Higher expression of Nrp1 in tip ECs compared with that in stalk ECs of angiogenic sprouts could differentially modulate &#x003b1;5&#x003b2;1 integrin traffic, thus favoring tip cell adhesion and spreading on FN. Finally, both Nrp1 &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b070">70</xref>&#x0005d; and &#x003b1;5&#x003b2;1 integrin &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b071">71</xref>,<xref ref-type="bibr" rid="pbio-1000025-b072">72</xref>&#x0005d; are expressed in pericytes and vascular smooth muscle cells, which have been implicated in vascular remodeling by intussusceptive angiogenesis &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b073">73</xref>&#x0005d;. Further work is needed to assess whether Nrp1 is regulating &#x003b1;5&#x003b2;1 integrin function not only in ECs but also in pericytes and vascular smooth muscle cells.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Antibodies, recombinant proteins, and growth factors.</title><p>Goat polyclonal anti-Nrp1 (C-19) and rabbit polyclonal anti-&#x003b2;-tubulin (H-235) were from Santa Cruz Biotechnology. Mouse monoclonal anti-human-Nrp1 (MAB 3870) was from R&#x00026;D Systems. Mouse monoclonal anti-FN (MAB88904) and anti-&#x003b1;v&#x003b2;3-integrin (MAB1976), goat polyclonal anti-&#x003b1;5&#x003b2;1-integrin (AB1950), rabbit polyclonal anti-&#x003b1;5-integrin (AB1928), rabbit polyclonal anti-&#x003b1;2-integrin (AB1936), and anti-&#x003b1;3-integrin (AB1920) were from Chemicon. Mouse monoclonal anti-human-vinculin (V9131) and rabbit polyclonal anti-Rab5 (R4654) were from Sigma-Aldrich. Rat monoclonal anti-HA (3F10) was from Roche. Rabbit polyclonal anti-GFP (A11122) and 4&#x02032;,6-diamidino-2-phenylindole (DAPI) were from Molecular Probes. Goat polyclonal anti-GIPC1 (ab5951) and rabbit polyclonal anti-Myo6 (ab11096) were from Abcam. Streptavidin&#x02013;horseradish peroxidase was from Amersham. Mouse monoclonal anti-active-&#x003b1;5-integrin, SNAKA51, was previously described &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b045">45</xref>&#x0005d;.</p><p>Human plasma FN was from Tebu-bio. Human plasma vitronectin, Engelbreth-Holm-Swarm murine sarcoma laminin, and calf skin collagen type I were from Sigma-Aldrich. Recombinant human VEGF-A165 was from Invitrogen. Recombinant human SEMA3A and mouse Sema3F were from R&#x00026;D Systems. Sulfo-NHS-SS-Biotin was from Pierce.</p></sec><sec id="s4b"><title>DNA constructs.</title><p>Hemagglutinin-tagged <italic>m</italic>Nrp1 deletion constructs were generated by standard PCR protocols according to the Taq polymerase manufacturer's instructions (Fynnzymes) and using an HA-tagged version of full-length <italic>m</italic>Nrp1 kindly donated by A. P&#x000fc;schel (Westf&#x000e4;lische Wilhelms-Universit&#x000e4;t, M&#x000fc;nster, Germany) as template. Cytoplasmic domains and the last three amino acids SEA were deleted using the following oligonucleotide primers: (i) 5&#x02032;-cgccatggagagggggctgccgttg-3&#x02032; (Fw); (ii) 5&#x02032;-ccaacaggcacagtacag-3&#x02032; (Re1) to amplify the <italic>m</italic>Nrp1 deleted of the cytoplasmic domain; (iii) 5&#x02032;-gtaattactctgtgggttc-3&#x02032; (Re2) to amplify the <italic>m</italic>Nrp1 deleted of the three amino acids SEA. The corresponding PCR product was first thymidine&#x02013;adenine (TA)-cloned into pCR2.1TOPO (Invitrogen) and subsequently subcloned in PINCO retrovirus or pAcGFP-N1 Vector (BD Bioscience) whose GFP coding sequence was previously substituted with the cDNA of mRFP, a kind gift of R. Tsien (University of California, San Diego, CA). &#x003b1;5-GFP and Rab5-GFP constructs were kindly provided, respectively, by A.F. Horwitz (University of Virginia, Charlottesville, VA) and M. Zerial (Max Plank Institute of Molecular Cell Biology and Genetics, Dresden, Germany).The &#x003b1;5-PA-GFP construct was previously described &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b051">51</xref>&#x0005d;.</p></sec><sec id="s4c"><title>siRNA.</title><p>The day before oligofection, ECs were seeded in six-well dishes at a concentration of 10 &#x000d7; 10<sup>4</sup> cells/well. Oligofection of siRNA duplexes was performed according to the manufacturer's protocols. Briefly, human ECs were transfected twice (at 0 and 24 h) with 200 pmol of siCONTROL nontargeting siRNA (as control), siGENOME SMART pools (in the case of <italic>h</italic>GIPC1 and <italic>h</italic>Myo6), or a mix of three (in the case of <italic>h</italic>Nrp1) siRNA oligonucletides (Dharmacon). After 24 h (in the case of <italic>h</italic>Nrp1) or 96 h (in the case of <italic>h</italic>GIPC1 or <italic>h</italic>Myo6) had passed since the second oligofection, ECs were lysed or tested in functional assays. In the case of <italic>h</italic>Nrp1, the single oligonucleotide sequences were: (1) 5&#x02032;-AAUCAGAGUUUCCAACAUA-3&#x02032;; (2) 5&#x02032;-GAAGGAAGGGCGUGUCUUG-3&#x02032;; (3) 5&#x02032;-GUGGAUGACAUUAGUAUUA-3&#x02032;.</p></sec><sec id="s4d"><title>Adhesion assay.</title><p>Six-thousand ECs were resuspended in 0.1 ml of EBM-2 (Clonetics) with or without appropriate stimuli (50 ng/ml VEGF-A, 200 ng/ml SEMA3A, and 400 ng/ml SEMA3F) and plated on 96-well microtiter plates (Costar) that were previously coated with ECM proteins at different concentrations and then saturated with 3&#x00025; bovine serum albumin. After 15 min of incubation at 37 &#x000b0;C, cells were fixed in 8&#x00025; glutaraldehyde and then stained with 0.1&#x00025; crystal violet in 20&#x00025; methanol. Cells were photographed with a QICAM Fast 1394 digital color camera (QImaging) and counted by means of Image-ProPlus 6.2 software (Media Cybernetics). In adhesion assays with NIH 3T3 fibroblasts or CHO cells, Dulbecco's modified Eagle's medium was used.</p></sec><sec id="s4e"><title>Immunoprecipitation and Western blotting.</title><p>Endothelial cells were lysed in buffer containing 25 mM Tris-HCl, pH 7.6, 100 mM NaCl, 0.15&#x00025; Tween-20, 5&#x00025; glycerol, 0.5 mM ethylene glycol tetraacetic acid (EGTA), and protease inhibitors (50 mg ml<sup>&#x02212;1</sup> pepstatin; 50 mg ml<sup>&#x02212;1</sup> leupeptin; 10 mg ml<sup>&#x02212;1</sup> aprotinin; 2 mM phenylmethanesulfonylfluoride (PMSF); 2 mM MgCl<sub>2</sub>). Cells were lysed in buffer, incubated for 20 min on wet ice, and then centrifuged at 15,000<italic>g</italic>, 20 min, at 4 &#x000b0;C. The total protein amount was determined using the bicinchoninic acid (BCA) protein assay reagent (Pierce). Equivalent amounts (1,200 &#x003bc;g) of protein were immunoprecipitated for 1 h with the antibody of interest, and immune complexes were recovered on Protein G-Sepharose (GE Healthcare). Immunoprecipitates were washed four times with lysis buffer, twice with the same buffer without Tween-20, and then separated by SDS-PAGE. Proteins were then transferred to a Hybond-C extra nitrocellulose membrane (Amersham), probed with antibodies of interest, and detected by an enhanced chemiluminescence technique (PerkinElmer).</p></sec><sec id="s4f"><title>Integrin internalization assay.</title><p>Integrin traffic assays were performed as previously described by Roberts et al. &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b050">50</xref>&#x0005d; with minor modifications. Cells were transferred to ice, washed twice in cold phosphate-buffered saline (PBS), and surface-labeled at 4 &#x000b0;C with 0.2 mg/ml sulfo-NHS-SS-biotin (Pierce) in PBS for 30 min. Labeled cells were washed in cold PBS and transferred to prewarmed EGM-2 at 37 &#x000b0;C. At the indicated times, the medium was aspirated, and dishes were rapidly transferred to ice and washed twice with ice-cold PBS. Biotin was removed from proteins remaining at the cell surface by incubation with a solution containing 20 mM sodium 2-mercaptoethanesulfonate (MesNa) in 50 mM Tris-HCl (pH 8.6), 100 mM NaCl for 1 h at 4 &#x000b0;C. MesNa was quenched by the addition of 20 mM iodoacetamide (IAA) for 10 min, and after other two further washes in PBS, the cells were lysed in 25 mM Tris-HCl, pH 7.4, 100 mM NaCl, 2 mM MgCl<sub>2</sub>, 1 mM Na<sub>3</sub>VO<sub>4</sub>, 0.5 mM EGTA, 1&#x00025; Triton X-100, 5&#x00025; glycerol, protease mix (Sigma), and 1 mM PMSF. Lysates were cleared by centrifugation at 12,000<italic>g</italic> for 20 min. Supernatants were corrected to equivalent protein concentrations by BCA assay, and integrins were isolated by immunoprecipitation and analyzed by SDS-PAGE.</p></sec><sec id="s4g"><title>RNA isolation and reverse transcription.</title><p>Cells were placed in RNA<italic>later</italic> solution (Ambion), kept at 4 &#x000b0;C for 24 h, and frozen at &#x02212;80 &#x000b0;C. After the cells were thawed on ice, total RNA was extracted following the manufacturer's recommended protocol (SV Total RNA Isolation System, Promega). The quality and integrity of the total RNA were quantified by means of the RNA 6000 Nano Assay kit in an Agilent 2100 bioanalyzer (Agilent Technologies). cDNAs were generated from 1 &#x003bc;g of total RNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems).</p></sec><sec id="s4h"><title>TaqMan real-time RT-PCR assay.</title><p>mRNA expression of FN and endogenous control genes, i.e., 18S rRNA, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and TATA binding protein (TBP), was measured in the samples by real-time RT-PCR using TaqMan Gene Expression Assays run on an ABI PRISM 7900HT Fast Real-Time PCR System (Applied Biosystems). The following assays were used: Hs00365058&#x0005f;m1 (FN), Hs99999901&#x0005f;s1 (18S rRNA), Hs99999905&#x0005f;m1 (GAPDH), and Hs00427620&#x0005f;m1 (TBP). Three replicates were run for each gene for each sample in a 384-well format plate (cDNA concentration 20 ng/well) according the manufacturer's protocol. Between the three measured endogenous control genes, we chose TBP for normalization, identified by geNorm &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b074">74</xref>&#x0005d;. The experimental threshold (Ct) was calculated using the algorithm provided by the SDS 1.9.1 software (Applied Biosystems). Ct values were converted into relative quantities using the method described here &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b075">75</xref>&#x0005d;. The amplification efficiency of each gene was calculated using a dilution curve and the slope calculation method &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b075">75</xref>&#x0005d;.</p></sec><sec id="s4i"><title>Conventional confocal scanning microscopy.</title><p>Cells were plated on glass coverslips coated with 1 &#x003bc;g/ml FN (TebuBio) and allowed to adhere for 3 h. In addition, ECs cotransfected with <italic>m</italic>Nrp1-mRFP and Rab5-GFP were then washed in PBS, incubated with 10 &#x003bc;g/ml SNAKA51 Ab in EBM-2 for 30 min at 4 &#x000b0;C, washed 3 times in PBS, transferred to prewarmed EGM-2, and allowed to recover at 37 &#x000b0;C for 2 min to induce endocytosis. Cells were washed in PBS, fixed in 4&#x00025; paraformaldehyde, permeabilized in 0.01&#x00025; saponin for 10 min on ice, and incubated or not with the Alexa-Fluor-405-conjugated secondary antibody (Molecular Probes) for 1 h at room temperature. Cells were analyzed by using a Leica TCS SP2 AOBS confocal laser-scanning microscope (Leica Microsystems). Immunofluorescence analysis was performed as previously described &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b016">16</xref>&#x0005d;.</p></sec><sec id="s4j"><title>Fibronectin fibrillogenesis.</title><p>Small interfering RNA silencing was performed, and after the second oligofection, cells were seeded onto glass coverslips in six-well dishes at a concentration of 20 &#x000d7; 10<sup>4</sup> cells/well and left to adhere for 3 h in EGM-2 medium (Clonetics) containing FN-depleted serum. Cells were then washed with PBS and fixed with 3.7&#x00025; paraformaldehyde for 20 min at room temperature. Next, cells were permeabilized in PBS containing 0.1&#x00025; Triton X-100 on wet ice for 2 min and incubated with anti-FN Ab for 1 h at room temperature. After three washes, cells were incubated with anti-mouse Alexa Fluor 555 for 45 min at room temperature and subsequently with DAPI. Cells were finally examined using a Leica TCS SP2 AOBS confocal laser-scanning microscope (Leica Microsystems).</p></sec><sec id="s4k"><title>FRET detection by TIRF/FLIM analysis.</title><p>Fluorescence resonance energy transfer was detected using a Lambert Instruments fluorescence attachment (LIFA) on a Nikon Eclipse TE 2000-U microscope, with the same changes to the condenser as described above and a filter block consisting of a Z473/10 excitation filter, a Z 488 RDC dichroic mirror, and a HQ 525/50M emission filter. The light source was a modulated 473-nm laser diode, which allows, in combination with the modulated intensifier from the LIFA system, measurement of fluorescence lifetimes using frequency domain. The laser was brought into TIRF mode before acquiring the images for the lifetime analysis.</p><p>Donor (D) lifetime, &#x003c4;, was analyzed either in the presence or in the absence of the acceptor (A), in adhesion sites, characterized by high donor concentrations, using the FLIM software (version 1.2.1.1.130; Lambert Instruments, The Netherlands). Fluorescence resonance energy transfer efficiency (E) was calculated as E &#x0003d; 1 &#x02013; (&#x003c4;DA/&#x003c4;D). Lifetime &#x003c4; was evaluated in four different areas (12 &#x000d7; 12 pixels) of seven &#x003b1;5-GFP and seven &#x003b1;5-GFP/<italic>m</italic>Nrp1-Cherry transfected NIH 3T3 cells. For statistical evaluation, results were analyzed with Student's <italic>t</italic> test.</p></sec><sec id="s4l"><title>TIRF-based photoactivation and time-lapse microscopy.</title><p>Total internal reflection fluorescence experiments have been performed on a Nikon Eclipse TE 2000-U microscope equipped with 60&#x000d7; and 100&#x000d7; 1.45 NA Nikon TIRF oil immersion objectives. The Nikon Epi-fluorescence condenser was replaced with a custom condenser in which laser light was introduced into the illumination pathway directly from the optical fiber output oriented parallel to the optical axis of the microscope. The light source for evanescent wave illumination was either a 473-nm diode, a 405-nm diode, or a 561-nm laser (Omicron), with each laser line coupled into the condenser separately to allow individual TIRF angle adjustments. Each laser was controlled separately by a DAC 2000 card or a uniblitz shutter operated by MetaMorph (Molecular Devices). A filter block consisting of an E480SPX excitation filter, a FF 495 dichroic mirror, and an ET 525/50M emission filter was used for activation of &#x003b1;5-PA-GFP with the 405-nm laser. After activation the filter was manually changed to a green/red dual filter block (ET-GFP/mCherry from AHF Analysentechnik, Germany) to allow simultaneous time-lapse acquisition of activated &#x003b1;5-PA-GFP and <italic>m</italic>Nrp1-Cherry using 473- and 561-nm excitation. A Multi-Spec dual emission splitter (Optical Insights, NM) with a 595-nm dichroic and two bandpass filters (510&#x02013;565 nm for green and 605&#x02013;655 nm for red) was used to separate both emissions. All cell imaging was performed with a Cascade 512F EMCCD camera (Photometrics UK).</p></sec><sec id="s4m"><title>Confocal photoactivation.</title><p>Localized activation of &#x003b1;5-PA-GFP in <italic>m</italic>Nrp1-Cherry-positive vesicles was done on a FV 1000 Olympus confocal microscope, using two-channel imaging and a separate SIM scanner for 405-nm activation &#x0005b;<xref ref-type="bibr" rid="pbio-1000025-b051">51</xref>&#x0005d;.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pbio-1000025-sg001"><label>Figure S1</label><caption><title>Analysis of the Influence of <italic>h</italic>Nrp1, <italic>h</italic>GIPC1, and <italic>h</italic>Myo6 Silencing on FN mRNA, protein levels, and Fibrillogenesis</title><p>(A&#x02013;F) Real-time RT-PCR (A&#x02013;C) and Western blot analyses (D&#x02013;F) on total RNAs and proteins extracted at different times of cell spreading in the absence of exogenously added extracellular matrices reveal that <italic>h</italic>Myo6 (C,F), but neither <italic>h</italic>Nrp1 (A,D) nor <italic>h</italic>GIPC1 (B,E), silencing reduce FN mRNA and protein levels. Vinculin was used as normalizer protein in Western blot analysis to calculate normalized optical density (NOD) units.</p><p>(G&#x02013;I) Confocal scanning microscopy analysis of endogenous FN fibrils in siCtl (G), si<italic>h</italic>GIPC1 (H), or si<italic>h</italic>Myo6 (I) transfected ECs. DAPI was used to stain nuclei. White bar in (I) corresponds to 50 &#x003bc;m.</p><p>(10.0 MB TIF)</p></caption><media xlink:href="pbio.1000025.sg001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio-1000025-sg002"><label>Figure S2</label><caption><title>Neither Full-Length <italic>m</italic>Nrp1 nor Its Deletion Constructs Modulates Cell Adhesion to VN</title><p><italic>m</italic>Nrp1, <italic>m</italic>Nrp1dSEA, or <italic>m</italic>Nrp1dCy overexpression does not affect the adhesion of NIH 3T3 fibroblasts to VN.</p><p>(825 KB TIF)</p></caption><media xlink:href="pbio.1000025.sg002.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio-1000025-sg003"><label>Figure S3</label><caption><title>Nrp1 Silencing Does Not Affect Either Total or Active &#x003b1;5&#x003b2;1 Integrin Levels in ECs</title><p>Immunoprecipitation of either total or active &#x003b1;5&#x003b2;1 followed by Western blot analysis for &#x003b1;5 shows that silencing Nrp1 in human ECs (si<italic>h</italic>Nrp1) does not alter &#x003b1;5 integrin expression compared with that of control silenced cells (siCtl).</p><p>(1.5 MB TIF)</p></caption><media xlink:href="pbio.1000025.sg003.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio-1000025-sg004"><label>Figure S4</label><caption><title>Rapid &#x003b1;5&#x003b2;1 Integrin Turnover in ECM Adhesions</title><p>As in <xref ref-type="fig" rid="pbio-1000025-g007">Figure 7</xref>, &#x003b1;5-PA-GFP was photoactivated in TIRF in NIH 3T3 cells and observed in time-lapse epifluorescence microscopy. Immediately after photoactivation, the &#x003b1;5-PA-GFP signal starts leaving the adhesive sites and accumulating in vesicles and disappears by &#x0223c;45 s in about 50&#x00025; of the adhesion sites and by &#x0223c;115 s in the remaining ones (see also <xref ref-type="supplementary-material" rid="pbio-1000025-sv002">Video S2</xref>).</p><p>(9.6 MB TIF)</p></caption><media xlink:href="pbio.1000025.sg004.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio-1000025-sg005"><label>Figure S5</label><caption><title>Upon Photoactivation in Areas outside of <italic>m</italic>Nrp1-Cherry-Positive Vesicles, &#x003b1;5-PA-GFP Does Not Recycle Back to Membrane Adhesions</title><p>NIH 3T3 cells were cotransfected with <italic>m</italic>Nrp1-Cherry and &#x003b1;5-PA-GFP. &#x003b1;5-PA-GFP integrin fluorescence was then locally photoactivated in an <italic>m</italic>Nrp1-Cherry-positive area devoid of vesicles (blue circle) and followed in time-lapse confocal microscopy. Fluorescence intensity was measured over time outside of Nrp1-positive vesicles (blue circle) and at the plasma membrane (red circle). The time-lapse plot (lower panel) shows that, under the same experimental conditions used in the experiment shown in <xref ref-type="fig" rid="pbio-1000025-g008">Figure 8</xref>, little or no photoactivation of &#x003b1;5-PA-GFP occurred, and no fluorescence intensity increase was detected at the plasma membrane (see also <xref ref-type="supplementary-material" rid="pbio-1000025-sv004">Video S4</xref>).</p><p>(9.4 MB TIF)</p></caption><media xlink:href="pbio.1000025.sg005.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio-1000025-sv001"><label>Video S1</label><caption><title>Rapid Turnover of &#x003b1;5&#x003b2;1 Integrin from Adhesion Sites into Nrp1-Positive Vesicles</title><p>As in <xref ref-type="fig" rid="pbio-1000025-g007">Figure 7</xref>, a representative NIH 3T3 cell was cotransfected with <italic>m</italic>Nrp1-Cherry and &#x003b1;5-PA-GFP, photoactivated in TIRF, and observed in time-lapse epifluorescence microscopy.</p><p>(4.3 MB MOV)</p></caption><media xlink:href="pbio.1000025.sv001.mov" mimetype="video" mime-subtype="quicktime"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio-1000025-sv002"><label>Video S2</label><caption><title>Rapid &#x003b1;5&#x003b2;1 Integrin Turnover in ECM Adhesions: Time-Lapse Epifluorescence Microscopy of &#x003b1;5-PA-GFP in the Representative NIH 3T3 Cell Shown in <xref ref-type="supplementary-material" rid="pbio-1000025-sg004">Figure S4</xref></title><p>(3.1 MB MOV)</p></caption><media xlink:href="pbio.1000025.sv002.mov" mimetype="video" mime-subtype="quicktime"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio-1000025-sv003"><label>Video S3</label><caption><title>Upon Photoactivation in <italic>m</italic>Nrp1-Cherry-Positive Vesicles, &#x003b1;5-PA-GFP Recycles Back to Membrane Adhesions</title><p>As in <xref ref-type="fig" rid="pbio-1000025-g008">Figure 8</xref>, a representative NIH 3T3 cell was cotransfected with <italic>m</italic>Nrp1-Cherry and &#x003b1;5-PA-GFP. &#x003b1;5-PA-GFP was locally photoactivated in vesicles containing <italic>m</italic>Nrp1-Cherry and followed by time-lapse confocal microscopy.</p><p>(9.7 MB MOV)</p></caption><media xlink:href="pbio.1000025.sv003.mov" mimetype="video" mime-subtype="quicktime"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio-1000025-sv004"><label>Video S4</label><caption><title>Upon Photoactivation in Areas outside of <italic>m</italic>Nrp1-Cherry-Positive Vesicles, &#x003b1;5-PA-GFP Does Not Recycle Back to Membrane Adhesions</title><p>As in <xref ref-type="supplementary-material" rid="pbio-1000025-sg005">Figure S5</xref>, a representative NIH 3T3 cell was cotransfected with <italic>m</italic>Nrp1-Cherry and &#x003b1;5-PA-GFP. &#x003b1;5-PA-GFP was locally photoactivated in an <italic>m</italic>Nrp1-Cherry-positive area devoid of vesicles and followed by time-lapse confocal microscopy.</p><p>(2.6 MB MOV)</p></caption><media xlink:href="pbio.1000025.sv004.mov" mimetype="video" mime-subtype="quicktime"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We acknowledge A.F. Horwitz, A. P&#x000fc;schel, R. Tsien, and M. Zerial for providing reagents. We thank Laura Di Blasio for helping us in setting up the integrin internalization assays. We are grateful to Stefano Biffo, Marco Arese, Letizia Lanzetti, Luca Primo, Christiana Ruhrberg, and Ivan Wall for critically reading the manuscript and for insightful discussions.</p></ack><glossary><title>Abbreviations</title><def-list><def-item><term>&#x003b1;5-GFP</term><def><p>GFP-tagged &#x003b1;5 integrin subunit</p></def></def-item><def-item><term>&#x003b1;5-PA-GFP</term><def><p>photoactivatable &#x003b1;5-GFP</p></def></def-item><def-item><term>&#x003c4;</term><def><p>lifetime</p></def></def-item><def-item><term>A</term><def><p>acceptor</p></def></def-item><def-item><term>Ab</term><def><p>antibody</p></def></def-item><def-item><term>Cherry</term><def><p>an improved version of mRFP</p></def></def-item><def-item><term>CHO B2</term><def><p>CHO cells lacking the &#x003b1;5 integrin subunit</p></def></def-item><def-item><term>CHO B2&#x003b1;27</term><def><p>CHO cells expressing the &#x003b1;5 integrin subunit</p></def></def-item><def-item><term>COLL-I</term><def><p>type I collagen</p></def></def-item><def-item><term>CUB</term><def><p>complement-binding</p></def></def-item><def-item><term>D</term><def><p>donor</p></def></def-item><def-item><term>E</term><def><p>FRET efficiency</p></def></def-item><def-item><term>ECs</term><def><p>endothelial cells</p></def></def-item><def-item><term>ECM</term><def><p>extracellular matrix</p></def></def-item><def-item><term>FLIM</term><def><p>fluorescence lifetime imaging microscopy</p></def></def-item><def-item><term>FN</term><def><p>fibronectin</p></def></def-item><def-item><term><italic>FN1,</italic></term><def><p>human fibronectin 1 gene</p></def></def-item><def-item><term>FRET</term><def><p>fluorescence resonance energy transfer</p></def></def-item><def-item><term>GFP</term><def><p>green fluorescent protein</p></def></def-item><def-item><term>GIPC1</term><def><p>GAIP interacting protein C terminus, member 1</p></def></def-item><def-item><term>HA</term><def><p>hemagglutinin</p></def></def-item><def-item><term><italic>h</italic>Nrp1</term><def><p>human full-length Nrp1</p></def></def-item><def-item><term>LN</term><def><p>laminin</p></def></def-item><def-item><term>mAb</term><def><p>monoclonal Ab</p></def></def-item><def-item><term>MAM</term><def><p>meprin/A5/&#x003bc;-phosphatase</p></def></def-item><def-item><term><italic>m</italic>Nrp1</term><def><p>full-length mouse Nrp1</p></def></def-item><def-item><term><italic>m</italic>Nrp1-Cherry</term><def><p>Cherry-tagged mNrp1</p></def></def-item><def-item><term><italic>m</italic>Nrp1dCy</term><def><p>murine Nrp1 lacking the whole cytoplasmic domain</p></def></def-item><def-item><term><italic>mNrp1dSEA</italic></term><def><p>murine Nrp1 lacking the C-terminal SEA amino acids</p></def></def-item><def-item><term><italic>m</italic>Nrp1-mRFP</term><def><p>mRFP-tagged mNrp1</p></def></def-item><def-item><term>mRFP</term><def><p>monomeric red fluorescent protein</p></def></def-item><def-item><term>Myo6</term><def><p>myosin 6</p></def></def-item><def-item><term>NOD</term><def><p>normalized optical density units</p></def></def-item><def-item><term>PMQ</term><def><p>primaquine</p></def></def-item><def-item><term>RNAi</term><def><p>RNA interference</p></def></def-item><def-item><term>Sema</term><def><p>murine semaphorin</p></def></def-item><def-item><term>SEMA</term><def><p>human semaphorin</p></def></def-item><def-item><term>SEMA3</term><def><p>class 3 SEMA</p></def></def-item><def-item><term>sFN</term><def><p>soluble FN dimers</p></def></def-item><def-item><term>siCtl</term><def><p>control nontargeting siRNA</p></def></def-item><def-item><term>si<italic>h</italic>GIPC1</term><def><p>siRNAs targeting human GIPC1</p></def></def-item><def-item><term>si<italic>h</italic>Myo6</term><def><p>siRNAs targeting human Myo6</p></def></def-item><def-item><term>si<italic>h</italic>Nrp1</term><def><p>siRNAs targeting <italic>h</italic>Nrp1</p></def></def-item><def-item><term>TIRF</term><def><p>total internal reflection fluorescence</p></def></def-item><def-item><term>VEGF</term><def><p>vascular endothelial growth factor</p></def></def-item><def-item><term>VN</term><def><p>vitronectin</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="pbio-1000025-b001"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serini</surname><given-names>G</given-names></name><name><surname>Valdembri</surname><given-names>D</given-names></name><name><surname>Bussolino</surname><given-names>F</given-names></name></person-group><year>2006</year><article-title>Integrins and angiogenesis: a sticky business</article-title><source>Exp Cell Res</source><volume>312</volume><fpage>651</fpage><lpage>658</lpage><pub-id pub-id-type="pmid">16325811</pub-id></citation></ref><ref id="pbio-1000025-b002"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hynes</surname><given-names>RO</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name></person-group><year>2000</year><article-title>The evolution of cell adhesion</article-title><source>J Cell Biol</source><volume>150</volume><fpage>F89</fpage><lpage>F96</lpage><pub-id pub-id-type="pmid">10908592</pub-id></citation></ref><ref id="pbio-1000025-b003"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hynes</surname><given-names>RO</given-names></name></person-group><year>2007</year><article-title>Cell-matrix adhesion in vascular development</article-title><source>J Thromb Haemost</source><volume>5</volume><issue>Suppl 1</issue><fpage>32</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">17635706</pub-id></citation></ref><ref id="pbio-1000025-b004"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Risau</surname><given-names>W</given-names></name><name><surname>Lemmon</surname><given-names>V</given-names></name></person-group><year>1988</year><article-title>Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis</article-title><source>Dev Biol</source><volume>125</volume><fpage>441</fpage><lpage>450</lpage><pub-id pub-id-type="pmid">3338622</pub-id></citation></ref><ref id="pbio-1000025-b005"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>T</given-names></name><name><surname>Larsen</surname><given-names>M</given-names></name><name><surname>Yamada</surname><given-names>KM</given-names></name></person-group><year>2003</year><article-title>Fibronectin requirement in branching morphogenesis</article-title><source>Nature</source><volume>423</volume><fpage>876</fpage><lpage>881</lpage><pub-id pub-id-type="pmid">12815434</pub-id></citation></ref><ref id="pbio-1000025-b006"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ginsberg</surname><given-names>MH</given-names></name><name><surname>Partridge</surname><given-names>A</given-names></name><name><surname>Shattil</surname><given-names>SJ</given-names></name></person-group><year>2005</year><article-title>Integrin regulation</article-title><source>Curr Opin Cell Biol</source><volume>17</volume><fpage>509</fpage><lpage>516</lpage><pub-id pub-id-type="pmid">16099636</pub-id></citation></ref><ref id="pbio-1000025-b007"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>MC</given-names></name><name><surname>Caswell</surname><given-names>PT</given-names></name><name><surname>Norman</surname><given-names>JC</given-names></name></person-group><year>2006</year><article-title>Endocytic recycling pathways: emerging regulators of cell migration</article-title><source>Curr Opin Cell Biol</source><volume>18</volume><fpage>549</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">16904305</pub-id></citation></ref><ref id="pbio-1000025-b008"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pellinen</surname><given-names>T</given-names></name><name><surname>Ivaska</surname><given-names>J</given-names></name></person-group><year>2006</year><article-title>Integrin traffic</article-title><source>J Cell Sci</source><volume>119</volume><fpage>3723</fpage><lpage>3731</lpage><pub-id pub-id-type="pmid">16959902</pub-id></citation></ref><ref id="pbio-1000025-b009"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pellinen</surname><given-names>T</given-names></name><name><surname>Arjonen</surname><given-names>A</given-names></name><name><surname>Vuoriluoto</surname><given-names>K</given-names></name><name><surname>Kallio</surname><given-names>K</given-names></name><name><surname>Fransen</surname><given-names>JAM</given-names></name><etal/></person-group><year>2006</year><article-title>Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of &#x003b2;1-integrins</article-title><source>J Cell Biol</source><volume>173</volume><fpage>767</fpage><lpage>780</lpage><pub-id pub-id-type="pmid">16754960</pub-id></citation></ref><ref id="pbio-1000025-b010"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>RH</given-names></name><name><surname>Alitalo</surname><given-names>K</given-names></name></person-group><year>2007</year><article-title>Molecular regulation of angiogenesis and lymphangiogenesis</article-title><source>Nat Rev Mol Cell Biol</source><volume>8</volume><fpage>464</fpage><lpage>478</lpage><pub-id pub-id-type="pmid">17522591</pub-id></citation></ref><ref id="pbio-1000025-b011"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>M</given-names></name><name><surname>Murakami</surname><given-names>Y</given-names></name><name><surname>Suto</surname><given-names>F</given-names></name><name><surname>Fujisawa</surname><given-names>H</given-names></name></person-group><year>2000</year><article-title>Determination of cell adhesion sites of neuropilin-1</article-title><source>J Cell Biol</source><volume>148</volume><fpage>1283</fpage><lpage>1293</lpage><pub-id pub-id-type="pmid">10725340</pub-id></citation></ref><ref id="pbio-1000025-b012"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soker</surname><given-names>S</given-names></name><name><surname>Takashima</surname><given-names>S</given-names></name><name><surname>Miao</surname><given-names>HQ</given-names></name><name><surname>Neufeld</surname><given-names>G</given-names></name><name><surname>Klagsbrun</surname><given-names>M</given-names></name></person-group><year>1998</year><article-title>Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor</article-title><source>Cell</source><volume>92</volume><fpage>735</fpage><lpage>745</lpage><pub-id pub-id-type="pmid">9529250</pub-id></citation></ref><ref id="pbio-1000025-b013"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olsson</surname><given-names>AK</given-names></name><name><surname>Dimberg</surname><given-names>A</given-names></name><name><surname>Kreuger</surname><given-names>J</given-names></name><name><surname>Claesson-Welsh</surname><given-names>L</given-names></name></person-group><year>2006</year><article-title>VEGF receptor signalling&#x02014;in control of vascular function</article-title><source>Nat Rev Mol Cell Biol</source><volume>7</volume><fpage>359</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">16633338</pub-id></citation></ref><ref id="pbio-1000025-b014"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>HQ</given-names></name><name><surname>Soker</surname><given-names>S</given-names></name><name><surname>Feiner</surname><given-names>L</given-names></name><name><surname>Alonso</surname><given-names>JL</given-names></name><name><surname>Raper</surname><given-names>JA</given-names></name><etal/></person-group><year>1999</year><article-title>Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165</article-title><source>J Cell Biol</source><volume>146</volume><fpage>233</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">10402473</pub-id></citation></ref><ref id="pbio-1000025-b015"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kusy</surname><given-names>S</given-names></name><name><surname>Funkelstein</surname><given-names>L</given-names></name><name><surname>Bourgais</surname><given-names>D</given-names></name><name><surname>Drabkin</surname><given-names>H</given-names></name><name><surname>Rougon</surname><given-names>G</given-names></name><etal/></person-group><year>2003</year><article-title>Redundant functions but temporal and regional regulation of two alternatively spliced isoforms of semaphorin 3F in the nervous system</article-title><source>Mol Cell Neurosci</source><volume>24</volume><fpage>409</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">14572462</pub-id></citation></ref><ref id="pbio-1000025-b016"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serini</surname><given-names>G</given-names></name><name><surname>Valdembri</surname><given-names>D</given-names></name><name><surname>Zanivan</surname><given-names>S</given-names></name><name><surname>Morterra</surname><given-names>G</given-names></name><name><surname>Burkhardt</surname><given-names>C</given-names></name><etal/></person-group><year>2003</year><article-title>Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function</article-title><source>Nature</source><volume>424</volume><fpage>391</fpage><lpage>397</lpage><pub-id pub-id-type="pmid">12879061</pub-id></citation></ref><ref id="pbio-1000025-b017"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaneko</surname><given-names>S</given-names></name><name><surname>Iwanami</surname><given-names>A</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Kishino</surname><given-names>A</given-names></name><name><surname>Kikuchi</surname><given-names>K</given-names></name><etal/></person-group><year>2006</year><article-title>A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord</article-title><source>Nat Med</source><volume>12</volume><fpage>1380</fpage><lpage>1389</lpage><pub-id pub-id-type="pmid">17099709</pub-id></citation></ref><ref id="pbio-1000025-b018"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Narazaki</surname><given-names>M</given-names></name><name><surname>Tosato</surname><given-names>G</given-names></name></person-group><year>2006</year><article-title>Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A</article-title><source>Blood</source><volume>107</volume><fpage>3892</fpage><lpage>3901</lpage><pub-id pub-id-type="pmid">16424390</pub-id></citation></ref><ref id="pbio-1000025-b019"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vacca</surname><given-names>A</given-names></name><name><surname>Scavelli</surname><given-names>C</given-names></name><name><surname>Serini</surname><given-names>G</given-names></name><name><surname>Di Pietro</surname><given-names>G</given-names></name><name><surname>Cirulli</surname><given-names>T</given-names></name><etal/></person-group><year>2006</year><article-title>Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma</article-title><source>Blood</source><volume>108</volume><fpage>1661</fpage><lpage>1667</lpage><pub-id pub-id-type="pmid">16684957</pub-id></citation></ref><ref id="pbio-1000025-b020"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guttmann-Raviv</surname><given-names>N</given-names></name><name><surname>Shraga-Heled</surname><given-names>N</given-names></name><name><surname>Varshavsky</surname><given-names>A</given-names></name><name><surname>Guimaraes-Sternberg</surname><given-names>C</given-names></name><name><surname>Kessler</surname><given-names>O</given-names></name><etal/></person-group><year>2007</year><article-title>Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis</article-title><source>J Biol Chem</source><volume>282</volume><fpage>26294</fpage><lpage>26305</lpage><pub-id pub-id-type="pmid">17569671</pub-id></citation></ref><ref id="pbio-1000025-b021"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guttmann-Raviv</surname><given-names>N</given-names></name><name><surname>Kessler</surname><given-names>O</given-names></name><name><surname>Shraga-Heled</surname><given-names>N</given-names></name><name><surname>Lange</surname><given-names>T</given-names></name><name><surname>Herzog</surname><given-names>Y</given-names></name><etal/></person-group><year>2006</year><article-title>The neuropilins and their role in tumorigenesis and tumor progression</article-title><source>Cancer Lett</source><volume>231</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">16356825</pub-id></citation></ref><ref id="pbio-1000025-b022"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>F</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Kalb</surname><given-names>RG</given-names></name><name><surname>Strittmatter</surname><given-names>SM</given-names></name></person-group><year>1998</year><article-title>Neuropilin-1 extracellular domains mediate semaphorin D/III-induced growth cone collapse</article-title><source>Neuron</source><volume>21</volume><fpage>1093</fpage><lpage>1100</lpage><pub-id pub-id-type="pmid">9856464</pub-id></citation></ref><ref id="pbio-1000025-b023"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>T</given-names></name><name><surname>Kitsukawa</surname><given-names>T</given-names></name><name><surname>Bekku</surname><given-names>Y</given-names></name><name><surname>Matsuda</surname><given-names>Y</given-names></name><name><surname>Sanbo</surname><given-names>M</given-names></name><etal/></person-group><year>1999</year><article-title>A requirement for neuropilin-1 in embryonic vessel formation</article-title><source>Development</source><volume>126</volume><fpage>4895</fpage><lpage>4902</lpage><pub-id pub-id-type="pmid">10518505</pub-id></citation></ref><ref id="pbio-1000025-b024"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>C</given-names></name><name><surname>Rodriguez</surname><given-names>ER</given-names></name><name><surname>Reimert</surname><given-names>DV</given-names></name><name><surname>Shu</surname><given-names>T</given-names></name><name><surname>Fritzsch</surname><given-names>B</given-names></name><etal/></person-group><year>2003</year><article-title>Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development</article-title><source>Dev Cell</source><volume>5</volume><fpage>45</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">12852851</pub-id></citation></ref><ref id="pbio-1000025-b025"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mukouyama</surname><given-names>YS</given-names></name><name><surname>Gerber</surname><given-names>HP</given-names></name><name><surname>Ferrara</surname><given-names>N</given-names></name><name><surname>Gu</surname><given-names>C</given-names></name><name><surname>Anderson</surname><given-names>DJ</given-names></name></person-group><year>2005</year><article-title>Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback</article-title><source>Development</source><volume>132</volume><fpage>941</fpage><lpage>952</lpage><pub-id pub-id-type="pmid">15673567</pub-id></citation></ref><ref id="pbio-1000025-b026"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruhrberg</surname><given-names>C</given-names></name><name><surname>Gerhardt</surname><given-names>H</given-names></name><name><surname>Golding</surname><given-names>M</given-names></name><name><surname>Watson</surname><given-names>R</given-names></name><name><surname>Ioannidou</surname><given-names>S</given-names></name><etal/></person-group><year>2002</year><article-title>Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis</article-title><source>Genes Dev</source><volume>16</volume><fpage>2684</fpage><lpage>2698</lpage><pub-id pub-id-type="pmid">12381667</pub-id></citation></ref><ref id="pbio-1000025-b027"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carmeliet</surname><given-names>P</given-names></name><name><surname>Ng</surname><given-names>YS</given-names></name><name><surname>Nuyens</surname><given-names>D</given-names></name><name><surname>Theilmeier</surname><given-names>G</given-names></name><name><surname>Brusselmans</surname><given-names>K</given-names></name><etal/></person-group><year>1999</year><article-title>Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188</article-title><source>Nat Med</source><volume>5</volume><fpage>495</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">10229225</pub-id></citation></ref><ref id="pbio-1000025-b028"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Behar</surname><given-names>O</given-names></name><name><surname>Golden</surname><given-names>JA</given-names></name><name><surname>Mashimo</surname><given-names>H</given-names></name><name><surname>Schoen</surname><given-names>FJ</given-names></name><name><surname>Fishman</surname><given-names>MC</given-names></name></person-group><year>1996</year><article-title>Semaphorin III is needed for normal patterning and growth of nerves, bones and heart</article-title><source>Nature</source><volume>383</volume><fpage>525</fpage><lpage>528</lpage><pub-id pub-id-type="pmid">8849723</pub-id></citation></ref><ref id="pbio-1000025-b029"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>JM</given-names></name><name><surname>Schwarz</surname><given-names>Q</given-names></name><name><surname>Ruhrberg</surname><given-names>C</given-names></name></person-group><year>2007</year><article-title>Selective requirements for NRP1 ligands during neurovascular patterning</article-title><source>Development</source><volume>134</volume><fpage>1833</fpage><lpage>1843</lpage><pub-id pub-id-type="pmid">17428830</pub-id></citation></ref><ref id="pbio-1000025-b030"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serini</surname><given-names>G</given-names></name><name><surname>Napione</surname><given-names>L</given-names></name><name><surname>Arese</surname><given-names>M</given-names></name><name><surname>Bussolino</surname><given-names>F</given-names></name></person-group><year>2008</year><article-title>Besides adhesion: new perspectives of integrin functions in angiogenesis</article-title><source>Cardiovasc Res</source><volume>78</volume><fpage>213</fpage><lpage>222</lpage><pub-id pub-id-type="pmid">18285512</pub-id></citation></ref><ref id="pbio-1000025-b031"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murga</surname><given-names>M</given-names></name><name><surname>Fernandez-Capetillo</surname><given-names>O</given-names></name><name><surname>Tosato</surname><given-names>G</given-names></name></person-group><year>2005</year><article-title>Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2</article-title><source>Blood</source><volume>105</volume><fpage>1992</fpage><lpage>1999</lpage><pub-id pub-id-type="pmid">15522955</pub-id></citation></ref><ref id="pbio-1000025-b032"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fukasawa</surname><given-names>M</given-names></name><name><surname>Matsushita</surname><given-names>A</given-names></name><name><surname>Korc</surname><given-names>M</given-names></name></person-group><year>2007</year><article-title>Neuropilin-1 interacts with integrin &#x003b2;1 and modulates pancreatic cancer cell growth, survival and invasion</article-title><source>Cancer Biol Ther</source><volume>6</volume><fpage>1173</fpage><lpage>1180</lpage><pub-id pub-id-type="pmid">17726369</pub-id></citation></ref><ref id="pbio-1000025-b033"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herzog</surname><given-names>Y</given-names></name><name><surname>Kalcheim</surname><given-names>C</given-names></name><name><surname>Kahane</surname><given-names>N</given-names></name><name><surname>Reshef</surname><given-names>R</given-names></name><name><surname>Neufeld</surname><given-names>G</given-names></name></person-group><year>2001</year><article-title>Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins</article-title><source>Mech Dev</source><volume>109</volume><fpage>115</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">11677062</pub-id></citation></ref><ref id="pbio-1000025-b034"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hallmann</surname><given-names>R</given-names></name><name><surname>Horn</surname><given-names>N</given-names></name><name><surname>Selg</surname><given-names>M</given-names></name><name><surname>Wendler</surname><given-names>O</given-names></name><name><surname>Pausch</surname><given-names>F</given-names></name><etal/></person-group><year>2005</year><article-title>Expression and function of laminins in the embryonic and mature vasculature</article-title><source>Physiol Rev</source><volume>85</volume><fpage>979</fpage><lpage>1000</lpage><pub-id pub-id-type="pmid">15987800</pub-id></citation></ref><ref id="pbio-1000025-b035"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Soker</surname><given-names>S</given-names></name><name><surname>Mukhopadhyay</surname><given-names>D</given-names></name></person-group><year>2003</year><article-title>Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration</article-title><source>J Biol Chem</source><volume>278</volume><fpage>48848</fpage><lpage>48860</lpage><pub-id pub-id-type="pmid">14514674</pub-id></citation></ref><ref id="pbio-1000025-b036"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>H</given-names></name><name><surname>Reed</surname><given-names>RR</given-names></name></person-group><year>1999</year><article-title>Cloning and characterization of neuropilin-1-interacting protein: a PSD-95/Dlg/ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1</article-title><source>J Neurosci</source><volume>19</volume><fpage>6519</fpage><lpage>6527</lpage><pub-id pub-id-type="pmid">10414980</pub-id></citation></ref><ref id="pbio-1000025-b037"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chittenden</surname><given-names>TW</given-names></name><name><surname>Claes</surname><given-names>F</given-names></name><name><surname>Lanahan</surname><given-names>AA</given-names></name><name><surname>Autiero</surname><given-names>M</given-names></name><name><surname>Palac</surname><given-names>RT</given-names></name><etal/></person-group><year>2006</year><article-title>Selective regulation of arterial branching morphogenesis by synectin</article-title><source>Dev Cell</source><volume>10</volume><fpage>783</fpage><lpage>795</lpage><pub-id pub-id-type="pmid">16740480</pub-id></citation></ref><ref id="pbio-1000025-b038"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yonekura</surname><given-names>H</given-names></name><name><surname>Sakurai</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Migita</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><etal/></person-group><year>1999</year><article-title>Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis</article-title><source>J Biol Chem</source><volume>274</volume><fpage>35172</fpage><lpage>35178</lpage><pub-id pub-id-type="pmid">10575000</pub-id></citation></ref><ref id="pbio-1000025-b039"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serini</surname><given-names>G</given-names></name><name><surname>Ambrosi</surname><given-names>D</given-names></name><name><surname>Giraudo</surname><given-names>E</given-names></name><name><surname>Gamba</surname><given-names>A</given-names></name><name><surname>Preziosi</surname><given-names>L</given-names></name><etal/></person-group><year>2003</year><article-title>Modeling the early stages of vascular network assembly</article-title><source>EMBO J</source><volume>22</volume><fpage>1771</fpage><lpage>1779</lpage><pub-id pub-id-type="pmid">12682010</pub-id></citation></ref><ref id="pbio-1000025-b040"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Esko</surname><given-names>J</given-names></name><name><surname>Giordano</surname><given-names>FJ</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><etal/></person-group><year>2004</year><article-title>Loss of HIF-1&#x003b1; in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis</article-title><source>Cancer Cell</source><volume>6</volume><fpage>485</fpage><lpage>495</lpage><pub-id pub-id-type="pmid">15542432</pub-id></citation></ref><ref id="pbio-1000025-b041"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>TT</given-names></name><name><surname>Barber</surname><given-names>CL</given-names></name><name><surname>Jordan</surname><given-names>MC</given-names></name><name><surname>Murdock</surname><given-names>J</given-names></name><etal/></person-group><year>2007</year><article-title>Autocrine VEGF signaling is required for vascular homeostasis</article-title><source>Cell</source><volume>130</volume><fpage>691</fpage><lpage>703</lpage><pub-id pub-id-type="pmid">17719546</pub-id></citation></ref><ref id="pbio-1000025-b042"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Kagoshima</surname><given-names>M</given-names></name><name><surname>Sasaki</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Udaka</surname><given-names>N</given-names></name><etal/></person-group><year>2000</year><article-title>Repulsive axon guidance molecule Sema3A inhibits branching morphogenesis of fetal mouse lung</article-title><source>Mech Dev</source><volume>97</volume><fpage>35</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">11025205</pub-id></citation></ref><ref id="pbio-1000025-b043"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Damon</surname><given-names>DH</given-names></name></person-group><year>2006</year><article-title>Vascular endothelial-derived semaphorin 3 inhibits sympathetic axon growth</article-title><source>Am J Physiol Heart Circ Physiol</source><volume>290</volume><fpage>H1220</fpage><lpage>H1225</lpage><pub-id pub-id-type="pmid">16258027</pub-id></citation></ref><ref id="pbio-1000025-b044"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Byzova</surname><given-names>TV</given-names></name><name><surname>Goldman</surname><given-names>CK</given-names></name><name><surname>Pampori</surname><given-names>N</given-names></name><name><surname>Thomas</surname><given-names>KA</given-names></name><name><surname>Bett</surname><given-names>A</given-names></name><etal/></person-group><year>2000</year><article-title>A mechanism for modulation of cellular responses to VEGF: activation of the integrins</article-title><source>Mol Cell</source><volume>6</volume><fpage>851</fpage><lpage>860</lpage><pub-id pub-id-type="pmid">11090623</pub-id></citation></ref><ref id="pbio-1000025-b045"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>K</given-names></name><name><surname>Pankov</surname><given-names>R</given-names></name><name><surname>Travis</surname><given-names>MA</given-names></name><name><surname>Askari</surname><given-names>JA</given-names></name><name><surname>Mould</surname><given-names>AP</given-names></name><etal/></person-group><year>2005</year><article-title>A specific &#x003b1;<sub>5</sub>&#x003b2;<sub>1</sub>-integrin conformation promotes directional integrin translocation and fibronectin matrix formation</article-title><source>J Cell Sci</source><volume>118</volume><fpage>291</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">15615773</pub-id></citation></ref><ref id="pbio-1000025-b046"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laukaitis</surname><given-names>CM</given-names></name><name><surname>Webb</surname><given-names>DJ</given-names></name><name><surname>Donais</surname><given-names>K</given-names></name><name><surname>Horwitz</surname><given-names>AF</given-names></name></person-group><year>2001</year><article-title>Differential dynamics of &#x003b1;5 integrin, paxillin, and &#x003b1;-actinin during formation and disassembly of adhesions in migrating cells</article-title><source>J Cell Biol</source><volume>153</volume><fpage>1427</fpage><lpage>1440</lpage><pub-id pub-id-type="pmid">11425873</pub-id></citation></ref><ref id="pbio-1000025-b047"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Woods</surname><given-names>AJ</given-names></name><name><surname>White</surname><given-names>DP</given-names></name><name><surname>Caswell</surname><given-names>PT</given-names></name><name><surname>Norman</surname><given-names>JC</given-names></name></person-group><year>2004</year><article-title>PKD1/PKC&#x003bc; promotes &#x003b1;v&#x003b2;3 integrin recycling and delivery to nascent focal adhesions</article-title><source>EMBO J</source><volume>23</volume><fpage>2531</fpage><lpage>2543</lpage><pub-id pub-id-type="pmid">15192707</pub-id></citation></ref><ref id="pbio-1000025-b048"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Axelrod</surname><given-names>D</given-names></name></person-group><year>2001</year><article-title>Total internal reflection fluorescence microscopy in cell biology</article-title><source>Traffic</source><volume>2</volume><fpage>764</fpage><lpage>774</lpage><pub-id pub-id-type="pmid">11733042</pub-id></citation></ref><ref id="pbio-1000025-b049"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wallrabe</surname><given-names>H</given-names></name><name><surname>Periasamy</surname><given-names>A</given-names></name></person-group><year>2005</year><article-title>Imaging protein molecules using FRET and FLIM microscopy</article-title><source>Curr Opin Biotechnol</source><volume>16</volume><fpage>19</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">15722011</pub-id></citation></ref><ref id="pbio-1000025-b050"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>M</given-names></name><name><surname>Barry</surname><given-names>S</given-names></name><name><surname>Woods</surname><given-names>A</given-names></name><name><surname>van der Sluijs</surname><given-names>P</given-names></name><name><surname>Norman</surname><given-names>J</given-names></name></person-group><year>2001</year><article-title>PDGF-regulated rab4-dependent recycling of alphavbeta3 integrin from early endosomes is necessary for cell adhesion and spreading</article-title><source>Curr Biol</source><volume>11</volume><fpage>1392</fpage><lpage>1402</lpage><pub-id pub-id-type="pmid">11566097</pub-id></citation></ref><ref id="pbio-1000025-b051"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caswell</surname><given-names>PT</given-names></name><name><surname>Spence</surname><given-names>HJ</given-names></name><name><surname>Parsons</surname><given-names>M</given-names></name><name><surname>White</surname><given-names>DP</given-names></name><name><surname>Clark</surname><given-names>K</given-names></name><etal/></person-group><year>2007</year><article-title>Rab25 associates with &#x003b1;5&#x003b2;1 integrin to promote invasive migration in 3D microenvironments</article-title><source>Dev Cell</source><volume>13</volume><fpage>496</fpage><lpage>510</lpage><pub-id pub-id-type="pmid">17925226</pub-id></citation></ref><ref id="pbio-1000025-b052"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zerial</surname><given-names>M</given-names></name><name><surname>McBride</surname><given-names>H</given-names></name></person-group><year>2001</year><article-title>Rab proteins as membrane organizers</article-title><source>Nat Rev Mol Cell Biol</source><volume>2</volume><fpage>107</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">11252952</pub-id></citation></ref><ref id="pbio-1000025-b053"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tani</surname><given-names>TT</given-names></name><name><surname>Mercurio</surname><given-names>AM</given-names></name></person-group><year>2001</year><article-title>PDZ interaction sites in integrin &#x003b1; subunits. TIP-2/GIPC binds to a type I recognition sequence in &#x003b1;<sub>6A</sub>/&#x003b1;<sub>5</sub> and a novel sequence in &#x003b1;<sub>6B</sub></article-title><source>J Biol Chem</source><volume>276</volume><fpage>36535</fpage><lpage>36542</lpage><pub-id pub-id-type="pmid">11479315</pub-id></citation></ref><ref id="pbio-1000025-b054"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Varsano</surname><given-names>T</given-names></name><name><surname>Dong</surname><given-names>M-Q</given-names></name><name><surname>Niesman</surname><given-names>I</given-names></name><name><surname>Gacula</surname><given-names>H</given-names></name><name><surname>Lou</surname><given-names>X</given-names></name><etal/></person-group><year>2006</year><article-title>GIPC is recruited by APPL to peripheral TrkA endosomes and regulates TrkA trafficking and signaling</article-title><source>Mol Cell Biol</source><volume>26</volume><fpage>8942</fpage><lpage>8952</lpage><pub-id pub-id-type="pmid">17015470</pub-id></citation></ref><ref id="pbio-1000025-b055"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Brunzelle</surname><given-names>JS</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><etal/></person-group><year>2007</year><article-title>Structure of the APPL1 BAR-PH domain and characterization of its interaction with Rab5</article-title><source>EMBO J</source><volume>26</volume><fpage>3484</fpage><lpage>3493</lpage><pub-id pub-id-type="pmid">17581628</pub-id></citation></ref><ref id="pbio-1000025-b056"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>DJ</given-names></name><name><surname>Noguchi</surname><given-names>T</given-names></name><name><surname>Miller</surname><given-names>KG</given-names></name></person-group><year>2004</year><article-title>Myosin VI: a structural role in actin organization important for protein and organelle localization and trafficking</article-title><source>Curr Opin Cell Biol</source><volume>16</volume><fpage>189</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">15196563</pub-id></citation></ref><ref id="pbio-1000025-b057"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vreugde</surname><given-names>S</given-names></name><name><surname>Ferrai</surname><given-names>C</given-names></name><name><surname>Miluzio</surname><given-names>A</given-names></name><name><surname>Hauben</surname><given-names>E</given-names></name><name><surname>Marchisio</surname><given-names>PC</given-names></name><etal/></person-group><year>2006</year><article-title>Nuclear myosin VI enhances RNA polymerase II-dependent transcription</article-title><source>Mol Cell</source><volume>23</volume><fpage>749</fpage><lpage>755</lpage><pub-id pub-id-type="pmid">16949370</pub-id></citation></ref><ref id="pbio-1000025-b058"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shraga-Heled</surname><given-names>N</given-names></name><name><surname>Kessler</surname><given-names>O</given-names></name><name><surname>Prahst</surname><given-names>C</given-names></name><name><surname>Kroll</surname><given-names>J</given-names></name><name><surname>Augustin</surname><given-names>H</given-names></name><etal/></person-group><year>2007</year><article-title>Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor</article-title><source>FASEB J</source><volume>21</volume><fpage>915</fpage><lpage>926</lpage><pub-id pub-id-type="pmid">17185751</pub-id></citation></ref><ref id="pbio-1000025-b059"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neufeld</surname><given-names>G</given-names></name></person-group><year>2007</year><article-title>Response to &#x0201c;Binding of the C-terminal amino acids of VEGF<sub>121</sub> directly with neuropilin-1 should be considered&#x0201d;</article-title><source>FASEB J</source><volume>21</volume><fpage>1293</fpage></citation></ref><ref id="pbio-1000025-b060"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheetz</surname><given-names>MP</given-names></name></person-group><year>2001</year><article-title>Cell control by membrane-cytoskeleton adhesion</article-title><source>Nat Rev Mol Cell Biol</source><volume>2</volume><fpage>392</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">11331914</pub-id></citation></ref><ref id="pbio-1000025-b061"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kinbara</surname><given-names>K</given-names></name><name><surname>Goldfinger</surname><given-names>LE</given-names></name><name><surname>Hansen</surname><given-names>M</given-names></name><name><surname>Chou</surname><given-names>FL</given-names></name><name><surname>Ginsberg</surname><given-names>MH</given-names></name></person-group><year>2003</year><article-title>Ras GTPases: integrins' friends or foes</article-title><source>Nat Rev Mol Cell Biol</source><volume>4</volume><fpage>767</fpage><lpage>776</lpage><pub-id pub-id-type="pmid">14570053</pub-id></citation></ref><ref id="pbio-1000025-b062"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ezratty</surname><given-names>EJ</given-names></name><name><surname>Partridge</surname><given-names>MA</given-names></name><name><surname>Gundersen</surname><given-names>GG</given-names></name></person-group><year>2005</year><article-title>Microtubule-induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase</article-title><source>Nat Cell Biol</source><volume>7</volume><fpage>581</fpage><lpage>590</lpage><pub-id pub-id-type="pmid">15895076</pub-id></citation></ref><ref id="pbio-1000025-b063"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miralles</surname><given-names>F</given-names></name><name><surname>Visa</surname><given-names>N</given-names></name></person-group><year>2006</year><article-title>Actin in transcription and transcription regulation</article-title><source>Curr Opin Cell Biol</source><volume>18</volume><fpage>261</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">16687246</pub-id></citation></ref><ref id="pbio-1000025-b064"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sweeney</surname><given-names>HL</given-names></name><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Zong</surname><given-names>AB</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Selvin</surname><given-names>PR</given-names></name><etal/></person-group><year>2007</year><article-title>How myosin VI coordinates its heads during processive movement</article-title><source>EMBO J</source><volume>26</volume><fpage>2682</fpage><lpage>2692</lpage><pub-id pub-id-type="pmid">17510632</pub-id></citation></ref><ref id="pbio-1000025-b065"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caswell</surname><given-names>P</given-names></name><name><surname>Norman</surname><given-names>J</given-names></name></person-group><year>2008</year><article-title>Endocytic transport of integrins during cell migration and invasion</article-title><source>Trends Cell Biol</source><volume>18</volume><fpage>257</fpage><lpage>263</lpage><pub-id pub-id-type="pmid">18456497</pub-id></citation></ref><ref id="pbio-1000025-b066"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Cheng</surname><given-names>W</given-names></name><name><surname>Hung</surname><given-names>J</given-names></name><name><surname>Montell</surname><given-names>D</given-names></name><name><surname>Geisbrecht</surname><given-names>E</given-names></name><etal/></person-group><year>2004</year><article-title>Lessons from border cell migration in the Drosophila ovary: a role for myosin VI in dissemination of human ovarian cancer</article-title><source>Proc Natl Acad Sci U S A</source><volume>101</volume><fpage>8144</fpage><lpage>8149</lpage><pub-id pub-id-type="pmid">15146066</pub-id></citation></ref><ref id="pbio-1000025-b067"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>TA</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Faith</surname><given-names>DA</given-names></name><name><surname>Hicks</surname><given-names>JL</given-names></name><name><surname>Platz</surname><given-names>EA</given-names></name><etal/></person-group><year>2006</year><article-title>A novel role of myosin VI in human prostate cancer</article-title><source>Am J Pathol</source><volume>169</volume><fpage>1843</fpage><lpage>1854</lpage><pub-id pub-id-type="pmid">17071605</pub-id></citation></ref><ref id="pbio-1000025-b068"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knudsen</surname><given-names>B</given-names></name></person-group><year>2006</year><article-title>Migrating with myosin VI</article-title><source>Am J Pathol</source><volume>169</volume><fpage>1523</fpage><lpage>1526</lpage><pub-id pub-id-type="pmid">17071577</pub-id></citation></ref><ref id="pbio-1000025-b069"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>CK</given-names></name><name><surname>Li</surname><given-names>JL</given-names></name><name><surname>Murga</surname><given-names>M</given-names></name><name><surname>Harris</surname><given-names>AL</given-names></name><name><surname>Tosato</surname><given-names>G</given-names></name></person-group><year>2006</year><article-title>Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function</article-title><source>Blood</source><volume>107</volume><fpage>931</fpage><lpage>939</lpage><pub-id pub-id-type="pmid">16219802</pub-id></citation></ref><ref id="pbio-1000025-b070"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamagishi</surname><given-names>H</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name><name><surname>Srivastava</surname><given-names>D</given-names></name></person-group><year>2000</year><article-title>The basic helix-loop-helix transcription factor, dHAND, is required for vascular development</article-title><source>J Clin Invest</source><volume>105</volume><fpage>261</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">10675351</pub-id></citation></ref><ref id="pbio-1000025-b071"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirschi</surname><given-names>KK</given-names></name><name><surname>Rohovsky</surname><given-names>SA</given-names></name><name><surname>D'Amore</surname><given-names>PA</given-names></name></person-group><year>1998</year><article-title>PDGF, TGF-&#x003b2;, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate</article-title><source>J Cell Biol</source><volume>141</volume><fpage>805</fpage><lpage>814</lpage><pub-id pub-id-type="pmid">9566978</pub-id></citation></ref><ref id="pbio-1000025-b072"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kale</surname><given-names>S</given-names></name><name><surname>Hanai</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>B</given-names></name><name><surname>Karihaloo</surname><given-names>A</given-names></name><name><surname>Grotendorst</surname><given-names>G</given-names></name><etal/></person-group><year>2005</year><article-title>Microarray analysis of in vitro pericyte differentiation reveals an angiogenic program of gene expression</article-title><source>FASEB J</source><volume>19</volume><fpage>270</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">15579670</pub-id></citation></ref><ref id="pbio-1000025-b073"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burri</surname><given-names>PH</given-names></name><name><surname>Hlushchuk</surname><given-names>R</given-names></name><name><surname>Djonov</surname><given-names>V</given-names></name></person-group><year>2004</year><article-title>Intussusceptive angiogenesis: its emergence, its characteristics, and its significance</article-title><source>Dev Dyn</source><volume>231</volume><fpage>474</fpage><lpage>488</lpage><pub-id pub-id-type="pmid">15376313</pub-id></citation></ref><ref id="pbio-1000025-b074"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vandesompele</surname><given-names>J</given-names></name><name><surname>De Preter</surname><given-names>K</given-names></name><name><surname>Pattyn</surname><given-names>F</given-names></name><name><surname>Poppe</surname><given-names>B</given-names></name><name><surname>Van Roy</surname><given-names>N</given-names></name><etal/></person-group><year>2002</year><article-title>Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes</article-title><source>Genome Biol</source><volume>3</volume><fpage>RESEARCH0034</fpage><pub-id pub-id-type="pmid">12184808</pub-id></citation></ref><ref id="pbio-1000025-b075"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pfaffl</surname><given-names>MW</given-names></name></person-group><year>2001</year><article-title>A new mathematical model for relative quantification in real-time RT-PCR</article-title><source>Nucleic Acids Res</source><volume>29</volume><fpage>e45</fpage><pub-id pub-id-type="pmid">11328886</pub-id></citation></ref></ref-list><fn-group><fn id="ack1" fn-type="con"><p><bold>Author contributions.</bold> DV, PTC, KIA, JCN, and GS conceived and designed the experiments. DV, PTC, JPS, IK, EA, and FC performed the experiments. DV, PTC, KIA, JPS, IK, EA, JCN, FB, and GS analyzed the data. KIA, JCN, and MJH contributed reagents/materials/analysis tools. DV, JPS, IK, JCN, FB, and GS wrote the paper.</p></fn><fn id="ack2" fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by grants from Telethon Italy (GGP04127 to GS), Associazione Augusto per la Vita (to GS), Fondazione Guido Berlucchi (to GS), Associazione Italiana per la Ricerca sul Cancro (to GS and FB), Ministero della Salute&#x02014;Programma Ricerca Oncologica 2006 and Ricerca Finalizzata 2006 (to GS and FB), Regione Piemonte&#x02014;Ricerca Sanitaria Finalizzata 2006 and 2008, Ricerca Scientifica Applicata 2004 grants D10 and A150, Ricerca Industriale e Sviluppo Precompetitivo 2006 grants PRESTO and SPLASERBA (to GS and FB), Sixth Framework Programme of European Union Contract LSHM-CT-2003&#x02013;503254 (to FB), Fondazione Cassa di Risparmio di Torino (to FB), the Wellcome Trust (to MJH), and Cancer Research UK (to JCN and KIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn><fn id="ack3" fn-type="conflict"><p><bold>Competing interests.</bold> The authors have declared that no competing interests exist.</p></fn></fn-group></back></article> 